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Status epilepticus (SE) describes a state of persistent seizures which are unrelenting.
First-line treatment for status epilepticus uses a group of drugs, the benzodiazepines,
that promote the action of the major inhibitory neurotransmitter within the brain,
gamma (γ)-aminobutyric acid (GABA). In a subset of patients however, benzodiazepines
prove to be ineffective in terminating SE.
Previous data from in vitro models has demonstrated that during single seizures, instead
of being inhibitory, activation of the GABAA receptor can have an excitatory effect on
neurons. To date, it is unknown whether this shift in GABAergic function contributes
to SE, nor how it may modulate the anticonvulsant properties of benzodiazepines. In
this thesis I explore the role of excitatory GABAergic signaling in an in vitro model of
SE and how this may affect the anticonvulsant efficacy of the benzodiazepine, diazepam.
Firstly, I confirm that benzodiazepine-resistant SE is prevalent in a South African
paediatric population. Secondly, consistent with its established mechanism of action,
I show that diazepam enhances GABAAR synaptic currents. Thirdly, using the in vitro
0 Mg2+ model of status epilepticus I show that whilst early application of diazepam
has anticonvulsant properties, this is lost when the drug is applied during prolonged
epileptiform activity. Fourthly, to investigate this phenomenon I use optogenetic
activation of GABAergic interneurons to show that interneurons can drive epileptiform
discharges during SE-like activity in vitro. Finally, I confirm that during seizure-like
events there is a transient shift in GABAergic signaling that is caused by activity driven
changes in the transmembrane Cl- gradient.
This thesis provides insight into how excitatory GABAergic signaling during prolonged
seizures may contribute towards benzodiazepine resistance in SE. I believe that these
results are relevant for understanding of the pathophysiology of SE and may help inform
optimal treatment protocols for this condition.
Acknowledgements
To my supervisor, Joe Raimondo, you have been incredible. Thank you for sharing your
passion for neuroscience with me, for always having an open door and above all, for
believing in me. You have enriched my life in so many wonderful ways and through it
all you have been a constant source of inspiration. Thank you.
To my co-supervisor, Arieh Katz, thank you for your selfless work in creating a platform
for medical students to engage with science. Your dedication to students is unparalleled.
To my mentors, Jo Wilmshurst and Graham Fieggen, thank you for being so generous
with your time and for always being there to support me.
To Andy Trevelyan and Colin Akerman, thank you for your invaluable input into this
project over the years.
To my fellow Raimondo Lab minions, thank you for always making the lab such a happy
place.
To Hayley, it has been such a privilege sharing this adventure with you right from the
start. Thank you for being the loving person that you are.
To my dear friends, thank you all for being such wonderful cheerleaders.
To my clinical partner, Dave, thank you for your patience and for always having my
back. It has been a pleasure spending my clinical years with you.
Für meine liebe Anna. Auch wenn du erst gegen Ende zu mir gestossen bist, warst du
umso wichtiger, um mich über diese Ziellinie zu bringen.
And finally to my beloved family. Mum, Dad and Greg, you have each played such a
significant part in this journey. None of what I have been able to achieve would have
been possible without you. I love you all very much.
Mum,
I dedicate this to you.
Contents
1 Introduction 7
1.1 GABAergic signalling: the principal player in fast synaptic inhibition . . . 7
1.1.1 Normal neuronal signalling: a balance between excitation and
inhibition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.1.2 The inhibitory network . . . . . . . . . . . . . . . . . . . . . . . . 8
1.1.3 Fast synaptic inhibition is mediated by the GABAA receptor . . . 9
1.1.4 The benzodiazepines: a class of GABAAR allosteric modulator . . 12
1.2 Chloride dynamics in the brain . . . . . . . . . . . . . . . . . . . . . . . . 13
1.2.1 Establishing the transmembrane chloride gradient in mature
neural tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.2.2 The state of the Cl- gradient determines the nature of GABAAR
function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.2.3 Studying GABAAR signalling & Cl
- dynamics . . . . . . . . . . . 15
1.2.4 Differential expression of CCCs causes long-term plasticity at the
GABA synapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.2.5 Activity-driven Cl- plasticity . . . . . . . . . . . . . . . . . . . . . 19
1.3 Alterations in Cl- dynamics and GABAAR signalling during seizures . . . 22
1.3.1 Seizures: unregulated hypersynchronous hyperexcitability . . . . . 22
1.3.2 Epilepsy: a global health burden . . . . . . . . . . . . . . . . . . . 23
1.3.3 In vitro models of epileptic seizures . . . . . . . . . . . . . . . . . . 23
1.3.4 Endogenous anticonvulsant mechanisms . . . . . . . . . . . . . . . 24
1.4 The relevance of excitatory GABAergic signalling in seizure activity . . . 25
1
CONTENTS
1.4.1 Depolarising GABAergic signalling within the ictal focus is caused
by changes in the expression of cation-chloride
co-transporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
1.4.2 Transient Cl- loading occurs during seizure activity . . . . . . . . . 27
1.4.3 Implications of depolarising GABAAR function on seizure dynamics 27
1.5 Status epilepticus & benzodiazepine resistance . . . . . . . . . . . . . . . 30
1.5.1 Unremitting & self-perpetuating seizure activity . . . . . . . . . . 30
1.5.2 Benzodiazepine resistance in status epilepticus . . . . . . . . . . . 31
1.5.3 Changes in GABAAR signalling during status epilepticus . . . . . 32
1.6 Aims & Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.6.1 Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2 Materials and Methods 35
2.1 Clinical data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.1.1 Study design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.2 Tissue preparation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.1 Animal tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.2 Organotypic brain slice cultures . . . . . . . . . . . . . . . . . . . . 38
2.2.3 Acute brain slices . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.2.4 Viral transfection . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.3 Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4 Intracellular recordings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4.1 Cell visualisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4.2 Whole-cell recordings . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.4.3 Perforated patch-clamp recordings . . . . . . . . . . . . . . . . . . 43
2.4.4 Calculating GABAAR parameters . . . . . . . . . . . . . . . . . . 44
2.5 Extracellular recordings . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.5.1 Local field potentials . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.6 Seizure models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.6.1 The 0 Mg2+ chemo-convulsant model . . . . . . . . . . . . . . . . 46
2.6.2 Definitions of in vitro seizure activity . . . . . . . . . . . . . . . . 46
Page 2 of 121
CONTENTS
2.7 Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.8 Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3 Results 49
3.1 Benzodiazepine-resistant status epilepticus is prevalent in a South African
paediatric cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2 Diazepam enhances GABAAR mediated signaling . . . . . . . . . . . . . . 52
3.2.1 Diazepam enhances the decay time constant, but not the
amplitude of light-induced GABAAR synaptic currents in
organotypic brain slices . . . . . . . . . . . . . . . . . . . . . . . . 54
3.2.2 Diazepam enhances both the amplitude and the decay time
constant of GABAAR synaptic currents in acute brain slices . . . . 56
3.3 0 Mg2+ is a reliable in vitro model of status epilepticus . . . . . . . . . . 59
3.3.1 The 0 Mg2+ model elicits prolonged seizure states in both
organotypic and acute brain slices . . . . . . . . . . . . . . . . . . 59
3.4 Differential effect of diazepam on the 0 Mg2+ in vitro model of status
epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.4.1 Early application of diazepam has a significant anticonvulsant
effect while late application augments bursting activity in the LRD
phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.5 GABAergic signalling is strongly depolarising during the late recurrent
discharge phase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.5.1 Optogenetic activation of interneurons drives excitatory signalling
in the evolution of prolonged seizure states . . . . . . . . . . . . . 69
3.5.2 Prolonged seizure activity leads to a significant decrease in light-
induced GABAergic conductances . . . . . . . . . . . . . . . . . . 71
3.6 Synchronised activation of GAD2 interneurons entrains network activity
during the LRD phase through GABAAR signalling . . . . . . . . . . . . 77
3.6.1 Synchronised activation of GAD2 interneurons is responsible for
entraining the hippocampal network during the LRD phase . . . . 79
3.7 Blocking the GABAAR reverses network entrainment via optogenetic
activation of GAD2 interneurons . . . . . . . . . . . . . . . . . . . . . . . 81
3.7.1 The frequency of epileptiform discharges during the LRD phase is
affected by synchronised activation of GAD2 interneurons . . . . . 83
3.8 Studying activity-driven changes in intracellular Cl- concentration . . . . 85
Page 3 of 121
CONTENTS
3.8.1 Both endogenous and exogenous GABA application can be used
to determine the intracellular concentration of Cl- in organotypic
brain slices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
3.8.2 Transient, activity-driven changes in intracellular Cl- occur during
single seizure-like events . . . . . . . . . . . . . . . . . . . . . . . . 88
4 Discussion 91
4.1 Benzodiazepine-resistant status epilepticus is prevalent within our local
paediatric population . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.2 Diazepam modulates GABAAR synaptic currents during normal network
activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
4.3 The 0 Mg2+ model provides a reliable in vitro replica of status epilepticus 94
4.4 Diazepam has a differential and time-dependent effect on in vitro status
epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
4.5 GABAergic signalling drives epileptiform discharges during in vitro status
epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.5.1 GABAergic signalling is excitatory in both single seizures and SE-
like activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.5.2 GABAergic signalling is reduced after prolonged seizure activity . 99
4.5.3 Photoactivation of GABAergic signalling entrains SE-like activity
through the GABAAR . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.6 Seizure-induced changes in Cl- . . . . . . . . . . . . . . . . . . . . . . . . 101
4.6.1 Using optogenetics to elicit GABAergic inhibitory signalling . . . . 101
4.6.2 Transient, activity-driven changes in intracellular Cl- during
single-seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.7 General discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.8 Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
Bibliography 106
A Appendix 119
A.1 Protocols for treating paediatric status epilepticus . . . . . . . . . . . . . 119
Page 4 of 121
List of Figures
1.1 The GABAAR is selectively permeable to Cl
- and HCO3
- . . . . . . . . . 10
1.2 Cation-chloride co-transporters set the transmembrane chloride gradient . 17
1.3 Activity-driven ionic plasticity precipitates a transient excitatory shift in
GABAAR-mediated signalling . . . . . . . . . . . . . . . . . . . . . . . . . 20
1.4 Cl- dynamics during seizure activity . . . . . . . . . . . . . . . . . . . . . 28
2.1 Using optogenetics to activate endogenous GABAergic signalling . . . . . 40
3.1 Local paediatric prevalence of benzodiazepine-resistant convulsive status
epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2 Diazepam enhances the decay time constant but not the amplitude of
light-induced GABAAR currents in organotypic brain slices . . . . . . . . 54
3.3 Diazepam enhances the amplitude and decay time constant of GABAAR
currents in acute brain slices . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.4 The 0 Mg2+ in vitro model of status epilepticus . . . . . . . . . . . . . . . 60
3.5 Differential effect of diazepam on the 0 Mg2+ model of status epilepticus
in organotypic brain slices . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.6 Population data showing the differential effect of diazepam on the 0 Mg2+
model of status epilepticus in organotypic brain slices . . . . . . . . . . . 67
3.7 Transient shifts in the effect of GABAergic interneurons during the during
the evolution of prolonged seizure activity . . . . . . . . . . . . . . . . . . 71
3.8 Activation of GAD2 interneurons results in depolarising currents in
pyramidal cells during single and prolonged seizures . . . . . . . . . . . . 73
3.9 Changes in baseline GABAergic signalling before and after prolonged
seizure activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5
LIST OF FIGURES
3.10 Photoactivation of GAD2 interneurons significantly increases discharge
probability in the LRD phase . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.11 Network entrainment follows optogenetic photoactivation of GAD2
interneurons during the LRD phase. . . . . . . . . . . . . . . . . . . . . . 79
3.12 The GABAAR antagonist, picrotoxin, decreased network entrainment by
photoactivation of GAD2 interneurons. . . . . . . . . . . . . . . . . . . . . 81
3.13 Synchronised photoactivation of GAD2 interneurons and blocking of the
GABAAR affects epileptiform discharge frequency during the LRD phase 84
3.14 Exogenous application of GABA versus optogenetic stimulated GAD2-
interneurons to determine intracellular concentration of Cl- in organotypic
brain slices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
3.15 Transient Cl- loading occurs during a single seizure-like event . . . . . . . 89
4.1 Disruptions to GABAAR structure and function may be responsible for
benzodiazepine-resistant status epilepticus . . . . . . . . . . . . . . . . . . 104
Page 6 of 121
Chapter 1
Introduction
1.1 GABAergic signalling: the principal player in fast
synaptic inhibition
1.1.1 Normal neuronal signalling: a balance between excitation and
inhibition
The sophisticated processing ability of the brain depends on the coordinated electrical
activity of neurons. Communication between neurons is made possible by a tightly
regulated ionic environment that produces the necessary electrochemical gradients to
facilitate synaptic signalling (Johnston and Wu, 1995).
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Communication between different brain cells largely, but not exclusively, occurs at
the synaptic junction (Shepherd, 2003). Here, the interaction between neurotransmitters
and their specific receptors directs the flow of electrical charge. These seceptors on
the postsynaptic membrane are linked to specific ion channels. When activated, these
channels open and permit a movement of charge that causes both positive and negative
shifts in the neuronal membrane potential.
Signals that precipitate membrane depolarisation, bringing it closer to the action
potential threshold, are termed excitatory. These are matched by inhibitory synaptic
inputs that cause membrane hyperpolarisation and thereby impede action potential
generation. A broad equilibrium between excitation and inhibition is critical to produce
the asynchronous firing patterns that underlie normal network function. However, under
certain conditions this state can can be disrupted. The consequence of this is either
uncontrolled excitation or prolonged inactivity, which are both dysfunctional.
1.1.2 The inhibitory network
The stability of neural networks is maintained by the inhibitory action of neurons
loosely termed inhibitory interneurons (Markram et al., 2004). The essential role
of inhibitory interneurons is evident in both their diversity and strategic positioning
throughout the brain. There is a large variety of these cells, each type with their own
morphology, firing pattern and distribution of synaptic contacts onto pyramidal cells.
At inhibitory synapses, inhibition is mediated by the presynaptic release of one of
two neurotransmitters: gamma (γ)-amino butyric acid (GABA) or glycine (Bowery and
Smart, 2006). GABA is the principal neurotransmitter which mediates fast synaptic
inhibition within the mature central nervous system (CNS) and will be the focus of my
thesis (Krnjević, 1974).
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1.1.3 Fast synaptic inhibition is mediated by the GABAA receptor
GABA is produced within the presynaptic terminal of what are referred to as
GABAergic interneurons, the major class of inhibitory interneurons. Interestingly,
GABA’s biosynthesis originates from the principal excitatory neurotransmitter,
glutamate, a reaction catalysed by the enzyme glutamate decarboxylase (Bak et al.,
2006). The inhibitory effects of GABA are generated through its binding to either
GABAA, GABAB or GABAC receptors (GABAARs, GABABRs and GABACRs)
(Bormann, 2000). The distribution of these different GABA receptors is responsible for
synaptic inhibition across various spatial and temporal contexts. Here I will specifically
focus on the role of the GABAAR in fast synaptic inhibition.
The GABAAR is a ligand-activated, ionotropic receptor (Olsen and Sieghart, 2009).
It is largely, but not exclusively, expressed on the postsynaptic membrane. Its structure
consists of a pentameric channel that is formed by different permutations of constitutive
subunits. The different subunits are separated into classes according to their varied
amino acid composition (α, β, γ, δ, ε, π, θ). Furthermore, some of these can be
sub-classified into different isoforms (α1-6, β1-3, γ1-3). It is the multiplicity of subunit
classes and isoforms that ultimately determines the biophysical properties of the channel
including its ligand binding capacity and conductance. The most commonly expressed
form of GABAAR pentamer includes the following combination: α1-β2-γ2-α1-β2. This
is further illustrated in Figure 1.1.
The GABAAR is activated by the binding of GABA at sites located between the α1
and β2 subunits. This induces a conformational change in the pentameric channel to
make it selectively permeable to Cl- influx and, to a lesser extent, bicarbonate (HCO3
-)
efflux (Kaila and Voipio, 1987; Kaila, 1994). Cl- and HCO3
- efflux occur at the same
time at an estimated ratio of 4:1 (Kaila and Voipio, 1987; Kaila et al., 1989; Kaila,
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1994). However, Cl- is predominant and because Cl- moves down its transmembrane
electrochemical gradient, under typical conditions there is an inward movement of
negative charge. This hyperpolarises the neuronal membrane and is referred to as an
inhibitory postsynaptic potential (IPSP).
The function of the GABAAR can be enhanced or impeded using various
pharmacological manipulations (Krogsgaard-Larsen et al., 1994; Olsen and Sieghart,
2009). GABAARs can be activated by agonists such as isoguvacine and muscimol.
GABAAR function can also be blocked by antagonists such as bicucullin and picrotoxin.
Furthermore, there are a growing selection of GABAAR positive allosteric modulators,
such as the benzodiazepines, that are able to enhance the GABAAR conductance.
Figure 1.1 (following page): The GABAAR is selectively permeable to Cl
- and HCO3
-. A,
The GABAAR is a pentameric channel that is expressed on the neuronal membrane. It is formed
from different combinations of subunits and is selectively permeable to both Cl- and HCO3
- ions.
The most common configuration is α1-β2-γ2-α1-β2. The channel is activated by the binding of
the neurotransmitter, γ-amino butyric acid (GABA, blue), at the junction between α1 and β2
subunits. The channel is then opened and allows for Cl- (green) and HCO3
- (orange) flux down
their respective electrochemical gradients in a ratio of 4:1. The benzodiazepines (red) are a class
of GABAAR allosteric modulators that bind onto the GABAAR at the junction of its γ and α
subunits. Under baseline conditions there is typically a low intracellular concentration of Cl-
([Cl-]i). B, When GABAARs are activated, the predominant flux of ions is Cl
- movement down
its electrochemical gradient into the cell. This influx of negative charge causes a membrane
hyperpolarisation. C, Benzodiazepines broadly increase the conductance of the GABAARs
by increasing the frequency at which the GABAAR opens. This increases the amplitude and
duration of the inhibitory postsynaptic potential (IPSP).
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1.1.4 The benzodiazepines: a class of GABAAR allosteric modulator
Benzodiazepines are a class of synthetic compounds, formed from the union
of the benzene and diazepine chemical rings (Müller and Wollert, 1973). By
enhancing GABAergic signalling they have anticonvulsant, sedative, hypnotic and
anxiolytic properties. The effect of benzodiazepines is determined by the different
subunit configurations of the GABAAR and their relative distribution throughout
the CNS. Furthermore, there are distinct pharmacological profiles for the different
benzodiazepine agents including different binding affinities to the different GABAAR
isoform configurations.
Benzodiazepines bind to the GABAAR between its γ and α subunits (Haefely et al.,
1993). Specifically, effective benzodiazepine binding onto the α subunit requires a
histidine residue (Wieland et al., 1992). This structural requirement for benzodiazepine
binding is present in all isoforms of the α subunit except α4 and α6 (Duncalfe and Dunn,
1996).
Upon binding, benzodiazepines are able to assert their effects by enhancing the
potency of GABA binding (Haefely et al., 1975). This results in an increase in the
frequency of channel opening, thereby increasing the conductance of the GABAAR.
Under typical conditions this facilitates the influx of the negatively charged Cl- ion and
enhances membrane hyperpolarisation.
Interestingly, there exists an endogenous equivalent to benzodiazepines known as the
endozepines (Costa and Guidotti, 1985; Farzampour et al., 2015). These compounds are
released by astrocytes and are also able to positively modulate GABAergic signalling
(Christian et al., 2013; Christian and Huguenard, 2013).
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The GABAAR is primarily a Cl
- channel with the effects of its activation being
determined by the state of the transmembrane Cl- gradient. The GABAAR’s inhibitory
function is therefore linked to the transmembrane Cl- gradient. However, this gradient is
dependent on both time and state, fluctuating as a function of development and network
activity.
1.2 Chloride dynamics in the brain
1.2.1 Establishing the transmembrane chloride gradient in mature
neural tissue
Two membrane cation-chloride co-transporters (CCCs) are primarily responsible for
setting the resting neuronal Cl- gradient (Kaila et al., 2014). These include the Na+-
K+-Cl- cotransporter (NKCC) and the K+-Cl- cotransporter (KCC). While there are
different configurations of these constructs, NKCC1 and KCC2 are the most prevalent
in establishing Cl- homeostasis in the brain. NKCC1 uses the Na+ gradient to actively
pump Cl- into the cell. Opposing this is KCC2 that uses the K+ gradient to facilitate
Cl- extrusion.
1.2.2 The state of the Cl- gradient determines the nature of GABAAR
function
To fully appreciate GABAAR function, first there needs to be an understanding of
how Cl- ions are directed through the channel (Johnston and Wu, 1995; Raimondo et al.,
2017).
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The current associated with GABAAR activation (IGABA) is the product of channel
conductance (gGABA) and driving force (DFGABA) as seen here in Equation 1.1.
IGABA = gGABA ×DFGABA (1.1)
The (DFGABA) is determined by the difference between the membrane potential and
the reversal potential for GABA (EGABA) highlighted in Equation 1.2.
DFGABA = V m − EGABA (1.2)
The reversal potential is defined as the membrane potential where the net ionic
current is 0. At this point the movement of ions through the GABAAR due to the electric
field is matched by the diffusion of ions down their concentration gradient (Raimondo
et al., 2015).
During normal baseline activity, the [Cl-]i is typically 5mM and the [Cl
-]e 123mM
(Raimondo et al., 2013; Ellender et al., 2014). The intracellular concentration of HCO3
-
([HCO3
-]i) is 15mM and the extracellular concentration of HCO3
- ([HCO3
-]e) is 24mM
(Kaila and Voipio, 1987; Kaila et al., 1989). Using these values, the EGABA (-70.6mV)
is calculated by combining the ECl (-80mV) and the EHCO3(-13mV) in a similar ratio
to their relative permeability (see Equation 1.3). As previously mentioned (see Section
1.1.3), the GABAAR is permeable to both Cl
- and HCO3
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The state of the [Cl-]i, which may differ in space and time, sets the EGABA that
then determines the polarity of GABAAR signalling (Wright et al., 2011). When EGABA
is negative relative to the resting potential (Vm), due to a low [Cl
-]i, it favours Cl
-
influx and membrane hyperpolarisation. This reduces the probability of action potential
generation and inhibits network excitability. If the EGABA were to rise, following an
increase in [Cl-]i, it can exceed Vm but still remain below the action potential threshold.
In this state GABAAR remains inhibitory as the increased Cl
- conductance counter-
balances the surrounding glutamate-mediated cation influx and thereby prevents further
depolarisation towards the AP threshold. This is known as shunting inhibition (Staley
and Mody, 1992). However, if the EGABA is more positive than the action potential
threshold, GABAAR activation can trigger a spike. When this occurs GABAergic
signalling has become excitatory (Staley et al., 1995).
1.2.3 Studying GABAAR signalling & Cl
- dynamics
There are various experimental techniques to elicit GABAAR-mediated currents.
These include the use of exogenous GABA or a selective GABAAR agonist like muscimol
(Forman et al., 2017). In addition, GABA-releasing interneurons can be activated
to release endogenous GABA. Traditionally, this has been achieved through electrical
stimulation of these GABAergic cells concurrent with glutamate receptor blockade (Ge
et al., 2006). More recently however, optogenetic stimulation has allowed for the
activation of interneurons either has a group or as individual interneuronal sub-groups.
This is achieved by expressing channelrhodopsin (ChR2), a light-sensitive Na+ channel,
selectively in interneuronal cells (Boyden et al., 2005). When a blue light is then used to
activate the opsin, the cells are depolarised and elicit action potentials that then initiates
endogenous GABA release at their synaptic targets (English et al., 2012; Ledri et al.,
2014).
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To explore changes in [Cl-]i, a variety of different electrical and imaging tools
are available. Imaging techniques include the use of Cl--sensitive dyes (Kovalchuk
and Garaschuk, 2012), or more recently, genetically encoded fluorescent reporters
(Grimley et al., 2013; Sato et al., 2017). However, a major limitation of these Cl-
imaging techniques is that they are affected by changes in intracellular pH that are
known to fluctuate along with neuronal activity, particularly seizures (Raimondo, Irkle,
Wefelmeyer, Newey and Akerman, 2012; Raimondo et al., 2013).
Electrophysiological methods include cell-attached recordings (Tyzio et al., 2008) and
perforated patch-clamp recordings (Kyrozis and Reichling, 1995). The main advantage
of these techniques is that they are not affected by fluctuations in intracellular pH.
Using this technique, EGABA is measured and the [Cl
-]i subsequently calculated using
the Nernst equation (see Equation 1.3). Perforated patch-clamp recordings are the
predominant technique used in this thesis to measure [Cl-]i.
The state of the transmembrane Cl- gradient can also be manipulated. Traditionally,
this has been achieved through genetic or pharmacological manipulation of NKCC2
(Flemmer et al., 2002; Dzhala et al., 2005) or KCC2 function (Hübner et al., 2001;
Deisz et al., 2014; Mahadevan and Woodin, 2016; Kelley et al., 2016). However, the
more recent development of optogenetic tools has provided a further ability to modulate
Cl- concentration. These include a chloride-specific pump (Raimondo, Kay, Ellender and
Akerman, 2012); a chloride-conducting channelrhodopsin (Berndt et al., 2014); an anion-
conducting channelrhodopsin (Govorunova et al., 2015) and a Cl- extruder (Alfonsa et al.,
2016).
The development of these advanced techniques has allowed scientists to investigate
and manipulate Cl- to explore its role in both development and disease.
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1.2.4 Differential expression of CCCs causes long-term plasticity at
the GABA synapse
As explained in Section 1.2.2, GABAAR-mediated signalling can be depolarising or
excitatory due to increases in [Cl-]i. These changes are thought to be driven by changes
in the expression patterns of NKCC1 and KCC2 that are relevant in both neurological
development and disease (Ben-Ari et al., 2012; Kaila et al., 2014).
In the developing brain, NKCC1 is up-regulated resulting in a higher intracellular
concentration of Cl- (Ben-Ari, 2002). In this state, GABA is depolarising and is thought
to be required in order to ‘unsilence’ glutamatergic synapses through the co-activation
of NMDA receptors (Wang and Kriegstein, 2008; van Rheede et al., 2015). However, as
neural tissues mature there is a down-regulation of NKCC1 which is accompanied by an
up-regulation of KCC2 (Rivera et al., 1999). In this mature state, there is increased Cl-
extrusion which results in a lower [Cl-]i and an inhibitory shift in GABA function. This
is further illustrated in Figure 1.2.
Figure 1.2 (following page): Cation-chloride co-transporters set the transmembrane chloride
gradient. The Na+/K+ ATPase sets the electrochemical gradient of Na+ and K+ across the
neuronal membrane. This gradient is then used by the cation-chloride co-transporters, NKCC1
and KCC2, in order to pump chloride in or out of the intracellular space. A, In the developing
brain, NKCC1 is upregulated allowing for a higher [Cl-]i and subsequently more positive EGABA
values. In this immature state, GABAAR-mediated signalling is depolarising and can facilitate
network excitation. B, As neural tissue matures, there is a down regulation of NKCC1 which is
accompanied by an upregulation of KCC2. KCC2 uses the K+ gradient to actively extrude Cl-.
In this state, there is a lower [Cl-]i, which allows for an inhibitory-shift in GABAAR function as
it becomes hyperpolarising. The relative differences in [Cl-]i and corresponding EGABA values
are shown here. This figure was adapted from Blaesse et al (2009) and Raimondo et al (2017).
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The role of CCCs has also been implicated in various disease states. Here disease-
associated changes in the NKCC1 and/or KCC2 expression profile alter inhibitory
signalling and overall network function. CCC-induced changes in [Cl-]i has been shown to
be involved in the pathophysiology of a growing number of complex disorders (Raimondo
et al., 2017). These include autism (Tang et al., 2016), neuropathic pain (Li et al., 2016),
schizophrenia (Tao et al., 2012), spasticity (Boulenguez et al., 2010) and, most relevant
to this thesis, epilepsy (Huberfeld et al., 2007).
1.2.5 Activity-driven Cl- plasticity
While CCCs are considered to be a fundamental factor in setting [Cl-]i, the state of
network activity can also significantly alter the state of the transmembrane Cl- gradient
(Raimondo, Kay, Ellender and Akerman, 2012; Raimondo et al., 2017).
During baseline network activity, EGABA is typically negative relative to the
resting membrane potential (Vm). When the GABAAR is activated, the state of the
transmembrane gradient favours Cl- influx causing membrane hyperpolarisation. KCC2
then uses the transmembrane K+ gradient to extrude Cl-. In this state, the inhibitory
function of the GABAAR is preserved by maintaining a low [Cl
-]i (Staley and Mody,
1992) and low [K-]e (Kaila et al., 1997).
An increase in network activity causes an increase in synaptic GABA release and
greater GABAAR activation (Staley and Proctor, 1999). This generates more Cl
- influx
and a subsequent rise in the [Cl-]i. The EGABA becomes positive relative to the Vm but
typically remains below the action potential threshold. In this state, GABAAR-mediated
signalling remains inhibitory by counteracting the net effect of the surrounding influx of
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cations through shunting inhibition (as explained in Section 1.2.2). The rise in [Cl-]i is
met by an increase in KCC2 activity in an attempt to re-establish the transmembrane
Cl- gradient. This is accompanied by increased K+ extrusion and a rise in the [K-]e
(Kaila et al., 1997).
If network activity increases further, the combined effect of the rising [Cl-]i and [K
-]e
soon overwhelms the Cl- extrusion capabilities of KCC2. This increased accumulation
of Cl- depolarises EGABA above the action potential threshold. In this state, with
subsequent GABAAR activation, action potentials will be triggered as GABAergic
signalling has become excitatory. This short term change in GABAAR signalling as
a function of a change in the transmembrane Cl- gradient is referred to as short-term
ionic plasticity and is further summarised in Figure 1.3.
Figure 1.3 (following page): Activity-driven ionic plasticity precipitates a transient excitatory
shift in GABAAR-mediated signalling. A, At rest, there is a low [Cl
-]i and EGABA is
hyperpolarised relative to the resting membrane potential (Vm). This allows Cl
- influx and
membrane hyperpolarisation. The low [K-]e allows for efficient KCC2-mediated extrusion of Cl
-.
B, During states of increased network activity, more GABA is released into the synaptic cleft
leading to enhanced GABAAR activation. This allows for a greater amount of Cl
- influx and rise
in the [Cl-]i, shifting the EGABA to sit above Vm but remain below the AP threshold. This allows
GABA to facilitate shunting inhibition. There is also increased KCC2 activity to try and correct
the [Cl-]i which may lead to an increased [K
-]e. C, When hyperexcitability is sustained, EGABA
depolarises above the AP threshold and GABAAR activation becomes excitatory and can trigger
APs. The rising [K-]e reduces the transmembrane K
+ gradient which impedes KCC2 function
and further facilitates the rise in [Cl-]i. This figure is adapted from Viitanen et al (2010) and
Raimondo et al (2017).
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1.3 Alterations in Cl- dynamics and GABAAR signalling
during seizures
1.3.1 Seizures: unregulated hypersynchronous hyperexcitability
Normal neuronal processing is typically characterised by asynchronous firing within
neural networks. This regulated activity is formed by excitation being broadly matched
by inhibition. However, if inhibitory processes are compromised, an unregulated
propagation of hyperexcitability may occur. In this state, network firing becomes
hypersynchronous and dysfunctional. This type of aberrant electrical activity is
understood to underlie what is referred to clinically as an ictus or seizure. Moreover, the
process that leads to this seizure activity is known as ictogenesis (Blauwblomme et al.,
2014).
Seizures can manifest clinically in a variety of both convulsive and non-convulsive
ways (Fisher et al., 2005). Seizure activity can occur following acute disruptions of
the brain (i.e. immediately following trauma) or following systemic disturbances (i.e.
metabolic dysfunction). If seizure initiation is unprovoked and recurrent, this clinical
presentation is referred to as the neurological disorder of epilepsy. Furthermore, the
pathological transition that occurs within the brain to generate unprovoked ictal activity
is called epileptogenesis (Goldberg and Coulter, 2013).
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1.3.2 Epilepsy: a global health burden
Across the world, epilepsy remains a significant health burden (Salomon et al., 2012).
Those affected are severely compromised, both by their seizures and from the side effects
of their treatment. While epilepsy remains a global problem, the majority of those who
suffer from it reside in resource-poor areas where access to care is limited (Ngugi et al.,
2011; Newton and Garcia, 2012). There is also a paucity of research describing epilepsy
epidemiology and treatment paradigms in this setting (Wilmshurst et al., 2014).
1.3.3 In vitro models of epileptic seizures
In vitro models of epileptic seizures provide a useful means for studying mechanisms
underlying seizures and for developing new therapeutic interventions. These in vitro
models typically use brain slices which have been prepared acutely (acute brain slices)
or slices which have been cultured over a period of days to weeks (organotypic brain
slices) (Pitkänen et al., 2017).
Traditionally, various chemo-convulsant paradigms have been used to induce seizure
activity using both the above-mentioned brain slice preparations. Disruptions to
GABAARs will readily induce seizure activity. This can be achieved by applying
GABAAR antagonists such as bicuculline (Griffiths et al., 1983; Borck and Jefferys,
1999) and picrotoxin (Hablitz, 1984) or by removing [Cl-]e (Avoli et al., 1990). Other
strategies include lowering or elevating the extracellular concentration of various ionic
species like Ca2+ (Jefferys and Haas, 1982; Yaari et al., 1983), K+ (Jensen and Yaari,
1988) or Mg2+ (Anderson et al., 1986). An advantage of the 0 Mg2+ model is that
it leaves GABAergic transmission intact. This allows for the study of how the GABA
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system might contribute to the evolution and propagation of seizures. This has been
demonstrated by Ellender et al (2014) who used a combination of both ionic changes and
electrical stimulation to initiate seizure-like events in order to study changes in GABA
signalling during seizures.
These in vitro models have allowed for an indepth investigation into the ion dynamics
that occur during seizure-like events (Raimondo et al., 2015, 2017). This has largely been
achieved using advanced electrophysiology including the use of ion-sensitive electrodes
(Dreier and Heinemann, 1991) and perforated patch-clamp recordings (Kyrozis and
Reichling, 1995). In addition, recent developments in imaging techniques have allowed
for fluctuations in Ca2+ (Badea et al., 2001) and Cl- (Raimondo, Irkle, Wefelmeyer,
Newey and Akerman, 2012; Sato et al., 2017) to be studied during in vitro epileptiform
activity using different biosensors and genetic reporters.
These in vitro models of seizures do have limitations in terms of accurately
representing in vivo conditions. However, they have provided an accessible way of
studying different aspects of both ictogeneis and epileptogenesis. This includes studying
the role GABAergic signalling plays in these processes.
1.3.4 Endogenous anticonvulsant mechanisms
Most seizures are self-limiting in that they stop of their own accord. This is
largely due to diverse endogenous anticonvulsant systems that are able to terminate
aberrant electrical activity. These systems include sophisticated and potent inhibitory
mechanisms that operate at the level of individual neurons and larger networks of neurons
(Lado and Moshé, 2008).
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The endogenous anticonvulsant mechanisms include pH fluctuations (Chesler and
Kaila, 1992) as well as glutamate depletion (Staley et al., 1998) and glutamate buffering
(Benarroch, 2005). In addition, during seizures there appears to be release of various
inhibitory neuromodulators including adenosine (Takigawa and Alzheimer, 2002; Ilie
et al., 2012), endocannabinoids (Lutz, 2004; Wallace et al., 2003), neuropeptide-Y
(Deborah Lin et al., 2006) and GABA (Wilson et al., 1996). The mechanisms involving
the GABAergic system are of particular relevance to this thesis.
Feed-forward and feedback GABAergic transmission is a major endogenous control
mechanism for regulating network excitability. (Trevelyan et al., 2007). This process is
mediated by GABA-releasing interneurons that increase their activity and the release of
GABA in response to elevated network activity. In so doing, they provide a significant
inhibitory barrier to the spread of seizures.
1.4 The relevance of excitatory GABAergic signalling in
seizure activity
Changes in intracellular Cl- dynamics and depolarising GABA have been implicated
in the initiation and propagation of seizures. This is summarised in Figure 1.4 and
further explained here.
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1.4.1 Depolarising GABAergic signalling within the ictal focus is
caused by changes in the expression of cation-chloride
co-transporters
Within epileptic tissue, there appears to be changes in the expression pattern of CCCs
that leads to a depolarising shift in GABAergic signalling. Huberfeld et al (2007) showed
this using resected epileptic brain tissue from human patients who had undergone surgery
to treat refractory epilepsy. Within this tissue, they noticed that in a significant subset
of pyramidal neurons GABAergic signalling was depolarising with this being caused by
a down-regulation of KCC2 and a upregulation of NKCC1. This finding suggests that
within an epileptic focus, an altered expression of CCCs results in GABAergic signalling
becoming permanently depolarising (as illustrated in Figure 1.4, A). These changes in
CCCs’ expression appear to be precipitated by neuronal injury either from ischaemia
(Pond et al., 2006), trauma (Nabekura et al., 2002) or following recurrent or prolonged
seizure activity (Rivera et al., 2004; Pathak et al., 2007; Lee et al., 2010).
To confirm the contribution of these CCCs to seizure activity, in vitro and in vivo
studies have used a variety of genetic and pharmacological techniques. Dzhala et al
(2005) showed that by blocking the function of NKCC1 with bumetanide, they could
drive a negative shift in EGABA as well as reduce epileptiform activity within immature
brain tissue. Moreover, Kelley et al (2016) have shown that compromising KCC2
function enhanced the development of seizure activity.
What is clear from this body of work is that long-term changes to Cl- transporters
and consequent perturbations of Cl- homeostasis is likely to contribute to the generation
of seizures. However, what is somewhat less well studied is how transient changes in
[Cl-]i might contribute to the evolution of seizure activity.
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1.4.2 Transient Cl- loading occurs during seizure activity
During individual seizures there is a transient depolarising shift in GABAergic
signalling (Ilie et al., 2012). This is likely caused by intense GABAAR activation,
Cl- influx and a subsequent increase in [Cl-]i (Raimondo, Kay, Ellender and Akerman,
2012; Ellender et al., 2014; Sato et al., 2017). A representation of these fluctuations is
illustrated in Figure 1.4, B. In this state, the activation of the GABAergic interneurons
can precipitate after-discharges (Fujiwara-Tsukamoto et al., 2010; Ilie et al., 2012;
Ellender et al., 2014). This observation suggests that interneurons may further drive
excitation. Importantly, both the [Cl-]i and EGABA return to their baseline levels after
the seizure activity has terminated with GABAergic signalling resuming its inhibitory
function.
Another contributor to this transient, seizure-associated increase in [Cl-]i is the
activity of KCC2 (Viitanen et al., 2010). Cl- extrusion is linked to K+ extrusion, hence
KCC2 activity during seizures leads to elevated [K+]e. This then combines with the effect
of increased channel-mediated K+ efflux to reduce the transmembrane K+ gradient. In
this state KCC2 extrusion is impaired and precipitates further accumulation of Cl- in
the intracellular space.
1.4.3 Implications of depolarising GABAAR function on seizure
dynamics
At the epileptic focus, the above-mentioned changes in CCCs expression and
function produce a chronically elevated Cl- state where GABAAR activation will remain
depolarising (as illustrated in Figure 1.4, A). This process is thought to provide a focus
for the generation of seizure activity. Surrounding this focus, Cl- extrusion mechanisms
are intact and [Cl-]i is maintained at low levels. This helps prevent the propagation
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of hyperexctability beyond the seizure focus. However, under certain conditions the
compensatory and intense activation of GABAAR signalling leads to a massive influx
of Cl- into the intracellular space. This can overwhelm otherwise normal Cl- extrusion
mechanisms causing the Cl- transmembrane gradient to collapse, resulting in a loss of
inhibitory function. When this inhibitory restraint is compromised, it allows a seizure to
propagate freely (Trevelyan et al., 2006; Schevon et al., 2012). Furthermore, under these
conditions it is possible that compromised GABAergic signalling may also exacerbate
the propagation of seizures.
Figure 1.4 (following page): Cl- dynamics during seizure activity. A, In healthy mature
neuronal tissue KCC2 is responsible for maintaining a low [Cl-]i. In the epileptic focus KCC2
appears dysfunctional or downregulated while NKCC1 is upregulated. This causes a significant
increase in [Cl-]i. B, A recording trace of a whole-cell patch-clamp recording in voltage-
clamp mode (-40mV) showing a 0 Mg2+-induced single seizure-like event from a hippocampal
organotypic slice culture. These events are characterised by 4 distinct phases. The pre-ictal
period shows an increase in network activity. The tonic phase is characterised by a sudden
depolarisation of the membrane accompanied by high-frequency and low-amplitude discharges.
The clonic phase is marked by rhythmic bursts or discharges. The post-ictal phase marks the
recovery period back to baseline activity. Previous experimental data from both perforated
patch-clamp and imaging experiments have shown a transient increase in [Cl-]i that occurs during
these single seizure-like events that then recovers to baseline when activity is terminated. This
is matched by fluctuations in [K+]e obtained from extracellular K
+-sensitive recordings. C, An
illustration of how seizure activity is believed to propagate within the cortex. At the ictal focus
both the Cl- and K+ gradients are perturbed, however in the surrounding penumbra, they are
intact. As seizure activity continues, the surrounding ion gradients are compromised leading
inhibition to become dysfunctional. This in turn allows the aberrant ictal activity to propagate.
Figure adapted from Raimondo et al (2015; 2017).
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Another important consideration is the possible effect these perturbed Cl- dynamics
could have on the anticonvulsant efficacy of pharmacological agents which enhance the
activity of GABAARs, such as the benzodiazepine class of drugs. Previous data from
Deeb et al (2013) has shown that the high [Cl-]i that accompanies hyperexcitable states
decreases the inhibitory effects of diazepam. Glykys et al (2015) then showed that
the inhibitory efficacy of diazepam correlates with the state of the transmembrane Cl-
gradient during development. In addition, Sivakumaran and Maguire (2016) show that
when NKCC1 is blocked, diazepam is more effective in reducing epileptiform activity in
immature tissue.
Therefore, the effect of disrupted neuronal Cl- on the efficacy of commonly used
anticonvulsants which target the GABAAR may be particularly relevant in the context
of prolonged seizure states such as status epilepticus.
1.5 Status epilepticus & benzodiazepine resistance
1.5.1 Unremitting & self-perpetuating seizure activity
Seizures are typically self-limiting and arrest within a few minutes in adults
(DeLorenzo et al., 1992), but in children individual seizures often last slightly longer
(Shinnar et al., 2001; Jenssen et al., 2006). Seizure termination is due to many
endogenous anticonvulsant mechanisms that can effectively limit ongoing seizure-activity
(as discussed in Section 1.3.4). However, under certain conditions, hyperexcitability
within the network persists.
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Status epilepticus (SE) is the clinical description of enduring and self-perpetuating
seizure activity. The recently revised definition now varies across different semiologies
with generalised convulsive SE (CSE) being the most common clinical presentation
(Trinka et al., 2015). SE is traditionally defined as a seizure persisting for ≥ 30 minutes.
However, it is now appreciated that seizures that do not self-abort within 5 minutes (or
recur continuously) are less likely to do so without therapeutic intervention. Therefore,
the practical definition of SE is any seizure that is ≥ 5 minutes in duration or multiple
discrete seizures between which there is no extended period of recovery between events.
The prolonged aberrant electrical activity of SE is accompanied by significant
morbidity and mortality (Betjemann and Lowenstein, 2015). In adults, mortality
associated with convulsive SE is estimated at around 20% (DeLorenzo et al., 1995). This
is largely determined by the underlying aetiology, with acute cerebrovascular events and
tumours being the most lethal. In children, SE appears to occur more frequently with
the most common presentation being prolonged febrile seizures (Chin et al., 2006).
1.5.2 Benzodiazepine resistance in status epilepticus
The current treatment guidelines for SE recommend the use of benzodiazepines as the
first line-agents (Trinka et al., 2016). These typically include either diazepam, lorazepam
or midazolam with them being equal in their anticonvulsant effect (Alldredge et al.,
2001). However, in a subset of patients, mostly children, these agents prove to be
ineffective (Appleton et al., 2000). When this occurs second-line agents come with a
more severe side effect profile (Chin et al., 2008).
The prevalence of benzodiazepine-resistant SE in children has not been described
within a South African context. Therefore, an objective of this thesis was to explore this
clinical phenomena in our local paediatric cohort (see Objective 1, Section 1.6.1).
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Pharmacoresistant SE has previously been studied using in vitro models, using
notably the Mg2+-free chemoconvulsant model in both acute (Dreier et al., 1998) and
organotypic (Albus et al., 2008) brain slices. In these experiments, a Mg-free aCSF
solution is used to promote excitation. From the time the Mg2+-free aCSF is washed in,
the network shows an evolution from single seizure-like events into a recurrent bursting
pattern of activity that has been termed the late recurrent discharge phase (LRD). This
LRD phase is thought to be an in vitro replica of the unrelenting hyperexcitability
underlying SE.
Using this Mg2+-free model, previous data has described a differential effect of
benzodiazepines (Zhang et al., 1995; Dreier et al., 1998). Benzodiazepines appear to
retain an anticonvulsant effect if introduced early by delaying the onset of seizure-like
events. However, if introduced once LRD had been established, the benzodiazepines
failed to show an anticonvulsant effect. A major objective of this thesis was to confirm
the effect of benzodiazepine on baseline inhibitory GABAergic signalling in brain slices
(see Objectives 2, Section 1.6.1). A subsequent objective was to investigate and quantify
differential effects of benzodiazepines on epileptiform activity in the 0 Mg2+ model of
SE (see Objectives 3 and 4, Section 1.6.1).
In trying understand what may underlie benzodiazepine-resistant SE, it is important
to consider the role of GABAergic signalling during these prolonged seizure states.
1.5.3 Changes in GABAAR signalling during status epilepticus
The unremitting aberrant network activity seen in SE is caused by a combination of
inhibitory failure as well as the recruitment of processes that facilitate ongoing network
excitation (Chen et al., 2007; Betjemann and Lowenstein, 2015). Specifically, changes
in GABAAR transmission are thought to contribute towards SE and will constitute the
major focus of this thesis.
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Previous data has suggested that after a certain period of ongoing seizure activity,
GABAARs are internalised (Kapur and Coulter, 1995; Goodkin et al., 2005; Naylor et al.,
2005; Goodkin and Kapur, 2009). This would result in a loss of GABAergic inhibitory
signalling, which could contribute to both prolonged seizure activity and the loss of
benzodiazepine efficacy.
Currently, there is no clear description of how GABAergic signalling might be affected
within the early phases of SE. Is GABAergic signalling reduced or does it become
excitatory during SE? I will address these question in Objectives 5 and 6 of this thesis
(see Section 1.6.1).
1.6 Aims & Objectives
The overall aim of this thesis was to investigate the role of activity-driven excitatory
GABAergic signalling on the propagation of prolonged seizures and how this may affect
benzodiazepine efficacy.
1.6.1 Objectives
The objectives of this thesis were as follows:
1. To explore the prevalence of benzodiazepine resistance in a local paediatric cohort
of patients presenting with SE.
2. To confirm that the anticonvulsant benzodiazepine, diazepam, positively
modulates GABAAR-mediated inhibitory signalling.
3. To setup and characterise an established in vitro model of SE using Mg2+
withdrawal in acute and organotypic brain slices.
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4. To study the effects of diazepam when applied at different time points in the 0
Mg2+ model of SE.
5. To study changes in GABAergic signalling in the development of prolonged seizure-
like states.
6. To investigate activity-driven changes in [Cl-]i.




The clinical data I present in this thesis was generated by performing an interim
analysis on the data being acquired from an ongoing clinical study.
2.1.1 Study design
A randomised and unblinded clinical trial was setup at the Medical Emergency
Unit at Red Cross War Memorial Children’s Hospital (RXH) in Cape Town, South
Africa. This is an equivalence trial with its main aim being to evaluate the use of two
protocols used in the second-line management of paediatric convulsive status epilepticus
(CSE). Both protocols (see Appendix A) start with repeated doses of benzodiazepines
as first-line management. If the CSE does not terminate after first-line management
has been given, patients are then randomised to one of the two second-line management
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protocols. The first protocol recommends the use of repeated doses of intravenous (IV)
phenobarbitone. The second protocol recommends IV phenytoin followed by an IV
midazolam infusion. This study was approved by the University of Cape Town Human
Research Ethics Council (UCT HREC 297/2005).
At admission patients are diagnosed with CSE primarily based on the history given
by the patient’s care-givers (or anyone who witnessed the event) along with what is
reported by the managing doctor. The definition of CSE includes any convulsive seizure
that extends beyond 5 minutes or multiple recurrent convulsive seizures with no return
to cognitive baseline in-between events (Trinka et al., 2015). Once the diagnosis is
made, patients are randomised to one of the treatment protocols. Randomisation of
protocols was done using the online platform, Research Randomizer (Urbaniak and
Plous, 2013). As the pharmacokinetic and side-effect profiles of the agents being
compared are distinctly different, it is not possible to blind the managing doctor or study
investigators from which intervention the patient has been assigned to. After admission,
further clinical information is captured retrospectively by reviewing the patient’s hospital
folder (obtained from the RXH Medical Records Department).
For this interim analysis, only paediatric patients (under 13 years of age) who
presented to the RXH Medical Emergency Department in CSE for the first time
were included. Patients readmitted with repeated episodes of CSE were excluded.
Furthermore, patients were excluded if they did not meet the clinical definition of CSE,
there was a deviation from the treatment protocol or if their clinical records could not
be traced.
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2.2 Tissue preparation
In my experiments I used brain slices of the hippocampus and entorhinal cortex
prepared from transgenic C57BL/6 mice. These brain areas were chosen due to their
significant abundance of GABAergic interneurons (Klausberger and Somogyi, 2008;
Melzer et al., 2012). Furthermore, both these areas are common epileptogenic foci
(Schwartzkroin, 1994; Avoli, 2007; Kumar and Buckmaster, 2006).
Two different preparations of mouse brain tissue were used: organotypic hippocampal
slices (organotypic brain slices) and acute hippocampal slices (acute brain slices). The
majority of experiments were performed in organotypic brain slices and, where possible,
experiments were repeated using acute brain slices. This was done to further validate
the results and to limit bias from a single in vitro model (Pitkänen et al., 2017). Due
to time and technical restraints, it was not possible to replicate all the experiments in
acute brain slices.
2.2.1 Animal tissue
The use of transgenic C57BL/6 in this thesis was approved by the University of
Cape Town Research Animal Unit Ethics Committee (project number 014/035). All
experiments used a crossed mouse strain on a C57BL/6 background. This strain
was a cross between mice expressing cre-recombinase in glutamic acid decarboxylase 2
(GAD2) positive interneurons (GAD2-cre) and mice with a loxP-flanked STOP cassette
preventing transcription of the red-fluorescent protein tdTomato (a cre-reporter strain).
This created the GAD2-cre-tdTomato strain which exposed the cre-recombinase and
tdTomato in all GABAergic interneurons as originally described by Taniguchi et al
(2011). All mice were purchased from Jackson Laboratory (USA).
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All mice used in this thesis were killed by decapitation in accordance with the South
African National Standard (SANS10386:2008) and the Veterinary and Paraveterinary
Professions Act (Act 19 of 1982). I am a registered member of the South African
Veterinary Council (AR14/1327) and am licensed to perform these decapitations.
Animal husbandry was provided by the UCT Animal Research Unit.
2.2.2 Organotypic brain slice cultures
Organotypic brain slices were prepared using 7 day old transgenic C57BL/6 mice
and followed the protocol originally described by Stoppini et al (1991). Mouse brains
were extracted and swiftly placed in cold (4°C) dissection media consisting of Geys
Balanced Salt Solution (GBSS #G9779, Sigma-Aldrich, USA) supplemented with D-
glucose (#G5767, Sigma-Aldrich, USA). The hemispheres were separated and individual
hippocampi were removed and immediately cut into 350 µm slices using a Mcllwain
tissue chopper (Mickle, UK). Cold dissection media was used to rinse the slices before
placing them onto Millicell-CM membranes (#Z354988, Sigma-Aldrich, USA). Slices
were maintained in culture medium consisting of 25% (vol/vol) Earles balanced salt
solution (#E2888, Sigma-Aldrich, USA); 49% (vol/vol) minimum essential medium
(#M2279, Sigma-Aldrich, USA); 25% (vol/vol) heat-inactivated horse serum (#H1138,
Sigma-Aldrich, USA); 1% (vol/vol) B27 (#17504044, Invitrogen, Life Technologies,
USA) and 6.2 g/l D-glucose. Slices were incubated in a 5% carbon dioxide (CO2)
humidified incubator at between 35 - 37°C.
Recordings were made after 6-14 days in culture. Previous studies have shown that
after 7 days in culture (equivalent to postnatal day 14) GABAergic signaling and EGABA
has sufficiently developed to a level resembling mature nervous tissue (Streit et al., 1989;
Tyzio et al., 2007; Raimondo, Kay, Ellender and Akerman, 2012).
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2.2.3 Acute brain slices
Transgenic C57BL/6 mice between 14 to 21 days old were used to prepare acute
brain slices. After decapitation, the mouse brain was extracted and quickly placed in a
50% sucrose cutting solution bubbled with carbogen gas (95% oxygen and 5% carbon
dioxide). The cutting solution used was composed of (in mM): NaCl (60); KCl (3);
NaH2PO4 (1.2); NaHCO3 (23); D-glucose (11); MgCl2 (3); CaCl2 (1) and sucrose (120).
pH was adjusted to between 7.38 and 7.42 using 0.1mM NaOH. The mouse brain was
then appropriately sectioned using a scalpel blade to ensure that the hippocampus and
entorhinal cortex would be sliced in the transverse plane. 400 µm horizontal slices were
cut using a vibrating VF-200 Compresstomer (Precisionary Instruments, USA). This
method of preparing acute brain slices is similar to that employed by Dreier et al (1991;
1998)
For patch-clamp experiments, slices were then transferred to a submerged chamber
which contained standard artificial cerebro-spinal fluid (aCSF) and bubbled with
carbogen gas. For local field potential recordings, slices were transferred to a custom-
built interface chamber (Krimer and Goldman-Rakic, 1997). The standard aCSF was
composed of (in mM): NaCl (120); KCl (3); MgCl2 (2); CaCl2 (2); NaH2PO4 (1.2);
NaHCO3 (23); D-Glucose (11) with pH adjusted to be between 7.35-7.40 using 0.1 mM
NaOH.
2.2.4 Viral transfection
After 1 day in culture, organotypic brain slices were transfected with adeno-
associated vector serotype 1 (AAV1) containing a floxed-STOP channelrhodopsin
(ChR2) linked to a yellow fluorescent protein (YFP) tag. The AAV1 has been shown
to be effective for viral transfection in organotypic brain slices (Royo et al., 2008).
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The AAV1-ChR2-YFP (UNC Vector Core, USA) was then diffusely injected into the
organotypic brain slices using a custom-built Openspritzer pressurised ejection device
(Forman et al., 2017). 6 days after injection, there was sufficient expression of the
ChR2-YFP. Figure 2.1 illustrates this optogenetic paradigm and further highlights how
it was used to activate endogenous GABAergic signalling.
Figure 2.1 (following page): Using optogenetics to activate endogenous GABAergic
signalling. A, Organotypic brains slices were prepared from the GAD2-cre-tdTomato mice
and transfected with an AAV1 containing a floxed-STOP ChR2-YFP. This allowed for selective
expression of ChR2 in all GABAergic interneurons. Confocal images demonstrate how ChR2-
YFP (green) is predominately expressed on the membrane of the GAD2-cre-tdTomato expressing
interneurons (red). B, ChR2 is a cation channel that is activated by blue light. Once activated
the channel permits cation influx facilitating membrane depolarisation and the generation of
action potentials. C, Whole-cell patch-clamp recordings in current-clamp mode from a ChR2-
expressing interneuron and a neighbouring pyramidal cell in an organotypic brain slice. Shining
blue light (17.1 mW) selectively activates interneurons as shown by how action potentials are
generated whenever the light stimulus is present. By contrast, the light stimulus generated
hyperpolarsing potentials in the pyramidal cell. These are GABAergic postsynaptic potentials.
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2.3 Imaging
The images presented in this thesis were acquired using a confocal microscope
(LSM510 Meta NLO, Car Zeiss, Jena, Germany). To visualise tdTomato expression
a 561 nm laser was utilised. To visualise YFP-labelled ChR2 a 488nm laser was utilised.
In each case, appropriate band pass filters were employed to collect emitted fluorescence.
2.4 Intracellular recordings
2.4.1 Cell visualisation
Brain slices were transferred to the recording chamber where they were continuously
superfused with standard aCSF using peristaltic pumps (400D1, Watson-Marlow, UK).
Neurons were visualized using a 20X water-immersion objective (XLUMPCFLN-W 20X,
Olympus, Japan) or a 40X water-immersion objective (LUMPLFLN 40X, Olympus,
Japan) on either a BX51WI upright microscope (Olympus, Japan) or an Axioskop
upright microscope (Zeiss, Germany). Digital images of the slices were obtained using a
CCD camera (VX55, TILL Photonics, Germany). In acute brain slices, visualization of
pyramidal cells was achieved with infrared differential interference contrast microscopy.
2.4.2 Whole-cell recordings
Micropipettes were prepared from borosilicate glass capillaries with an outer diameter
of 1.20mm and inner diameter of 0.69mm (Warner Instruments, USA), using a horizontal
puller (Intracell Model P-1000, Sutter, USA). When recording GABAergic synaptic
currents, pipettes were filled with a high Cl- internal solution (Cl- 141mM) composed
of (in mM): KCl (135), NaCl (8.9) and HEPES (10). When recording seizure activity,
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pipettes were filled with an internal solution (Cl- 10mM) composed of (in mM): K-
gluconate (120); KCl (10); Na2ATP (4); NaGTP (0.3); Na2-phosphocreatinine (10) and
HEPES (10). The pipettes were then placed over a silver wire electrode attached to a
CV 203BU head stage (Molecular Devices, USA) which was controlled using motorised
micromanipulators (Luigs and Neuman, Germany). Positive pressure was applied and
the pipette was lowered onto the surface of the target cell. Once a membrane gigaseal had
formed, pipette capacitance was compensated. Break-through was achieved with gentle
negative pressure and defined as a drop of access resistance to <20 MΩ. Recordings
were made in both current-clamp and voltage-clamp modes using an Axopatch 200B
amplifier (Molecular Devices, USA) with data being acquired with either IGOR Pro
software (Wavemetrics, USA) or WinWCP (University of Strathclyde, Scotland).
2.4.3 Perforated patch-clamp recordings
To perform gramicidin perforated patch-clamp recordings, I followed the protocol
described by Kyrozis and Reichling (1995). The advantage of this recording technique is
that it preserves [Cl-]i. Micropipettes were filled with the high Cl
- (described in Section
2.4.2). The osmolarity of all internal solutions was adjusted to 290 mOsM and the
pH adjusted to 7.38 with NaOH. Gramicidin A (90% pure, Sigma, USA) was dissolved
in dimethylsulfoxide (DMSO, Sigma, USA) to achieve a stock solution of 4 mg/ml.
Before each recording, a working internal solution was prepared by diluting 5µL of
Gramicidin stock in 995µL of the high Cl- internal solution to achieve a final gramicidin
concentration of 80µg/ml. The solution was then sonicated and mixed on a rotamixer
before being filtered with a 0.45 microm cellulose acetate membrane filter (Merck, USA).
Patch pipettes (described in Section 2.4.2) were then back filled with gramicidin working
solution. Positive pressure was applied and the pipette was lowered onto the surface
of the target cell. Once a membrane gigaseal had formed, pipette capacitance was
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compensated. Adequate perforation of the membrane was assessed by monitoring access
resistance and was defined when access resistance was <50 MΩ. This usually occurred
between 10-45 minute after gigaseal had formed. Recordings were made in both current-
clamp and voltage-clamp modes using an Axopatch 200B amplifier (Molecular Devices,
USA) with data being acquired with WinWCP (University of Strathclyde, Scotland).
Rupture of the gramicidin patch, referred to as a break through, causes massive influx
of the high Cl- internal solution into the cell. This causes a significant and permanent
increase in the EGABA at which time recordings would be discarded.
2.4.4 Calculating GABAAR parameters
In order to study GABAAR function, EGABA and gGABA were calculated. This
was achieved by activating GABAARs either with endogenous or exogenous GABA.
Endogenous GABA was released by either stimulating ChR2-expressing interneurons
with light (in organotypic brain slices), or by electrically stimulating GAD2-interneurons
in the presence of glutamate receptor blockade (in acute brain slices). Light stimulus
was typically set at 100ms and LED intensity of 17.1 mW. The electrical stimulus was
set at 2pA for 3ms. Alternatively, exogenous GABA (#0344, Torcis Bioscience, United
Kingdom) was puffed onto the cell using an Opensprizter device (Forman et al., 2017).
In order to calculate resting EGABA and gGABA, peak GABAAR currents were elicited
at different stepped voltages (a series of 10mV steps above and below a set resting
potential of -60mV). Between each recording sweep there was a 10-30s break to allow
for adequate recovery of [Cl-]i. The peak GABAAR currents at each voltage were then
plotted against the holding potential to generate a current-voltage (I-V) curve. Using this
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graph the resting EGABA was defined as the x-intercept of the peak GABAAR currents
and holding potential. Applying Equations 1.1 and 1.2, gGABA could be calculated.
Furthermore, the [Cl-]i could be calculated from EGABA by way of the Nernst Equation
(see Equation 1.3).
2.5 Extracellular recordings
2.5.1 Local field potentials
For local field potentials, slices were placed in an interface recording chamber (Krimer
and Goldman-Rakic, 1997) perfused with aCSF using a peristaltic pump (Model 205S
Watson-Marlow, UK). Temperature was adjusted to ensure the solution in the chamber
surrounding the slice was kept between 33 - 35°C.
Single-electrode extracellular recordings were performed using patch pipettes (similar
to those described in Section 2.4.2) with their tips broken under microscope visualisation
using a VT-II 2147861 microscope (Olympus, Japan). Pipettes were filled with Mg2+-
free aCSF and lowered onto brain slices under microscope guidance. For organotypic
brain slices, pipettes were placed in the CA1 region while in acute brain slices they were
placed in the entorhinal cortex. Adequate contact was defined by visualising the pipette
tip breaking the surface of the perfusing solution above the slice.
Recordings were performed using a 1800 2-Channel Microelectrode AC amplifier (A-
M Systems, USA) and associated headstages attached to silver-wire electrodes. Data
was acquired using the PowerLab 15T hardware (AD Instruments, New Zealand) and
LabChart Pro software package (AD Instruments, New Zealand). Recordings were
processed using a digital low-pass filter at 140Hz. During analysis an additional digital
high-pass filter at 0.1Hz was applied.
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2.6 Seizure models
2.6.1 The 0 Mg2+ chemo-convulsant model
To elicit in vitro epileptiform activity, slices were bathed in Mg2+-free aCSF
(Anderson et al., 1986; Mody et al., 1987; Dreier and Heinemann, 1991; Albus et al.,
2008). Removing extracellular Mg2+ reduces the voltage dependent block of Mg2+ on N-
methyl-D-aspartic acid (NMDA) receptors. When this occurs, the brain slices become
predisposed to developing synchronised and sustained hyperexcitability that initially
manifests as single seizure-like events (SLEs). Over time this activity then progresses
into recurrent epileptiform discharges referred to as the late recurrent discharge (LRD)
phase.
2.6.2 Definitions of in vitro seizure activity
SLEs recorded using whole-cell patch-clamp recordings were defined as a significant
depolarisation (2 standard deviations above the resting membrane potential) that lasted
at least 5 seconds while following the typical tonic-clonic pattern (illustrated in Figure
1.4). These were represented as upward deflections in current-clamp mode and downward
deflections in voltage-clamp mode. When using extracellular recordings, SLEs were
defined as a change in the local field potential that was at least 2 standard deviations
away from the baseline activity and lasted for a period of at least 5 seconds.
The LRD phase was defined as recurrent discharges (termed epileptiform discharges)
that persist for at least 2 minutes with no return to baseline. This definition was guided
by previous in vitro work (Zhang et al., 1995; Dreier and Heinemann, 1991; Dreier et al.,
1998). Furthermore, as the LRD aims to model clinical SE, this definition aims to align
with the revised clinical definition of SE (Trinka et al., 2015).
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Data was excluded from analysis if electrical noise prevented accurate identification
of SLEs or LRD. In addition, slices that developed spontaneous seizures prior to being
exposed to 0 Mg2+ were also excluded. This was done to prevent any potential kindling
process whereby prior seizure activity could alter various properties of the neuronal
network, specifically in the GABAergic system. These changes could affect SLE and
LRD propensity. (Kamphuis et al., 1991; Morimoto et al., 2004)
2.7 Drugs
Here the various drugs used will be described. Their exact application is explained
in greater detail with the relevant experiments presented in Chapter 3.
The following drugs were added to the aCSF solution in the course of various
experiments: the GABAAR agonist, diazepam (#2805, Torcis Bioscience, United
Kingdom); the benzodiazepine competitive antagonist, flumazenil (#1328, Torcis
Bioscience, United Kingdom); the GABABR antagonist, CGP-35348 (#1248, Torcis
Bioscience, United Kingdom) and the glutamate receptor antagonist, kynurenic acid
(#0223, Torcis Bioscience, United Kingdom). Where applicable, the intracellular Na+
channel blocker QX-314 (#1014, Torcis Bioscience, United Kingdom) was added to the
internal solution used to fill patch pipettes.
As diazepam is classified as a schedule 4 restricted substance within South Africa, an
import and possession permit was obtained from the South African Medicines Control
Council (IMP/123/2016 and Permit No: 033/2016/2017).
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2.8 Data analysis
Data analysis was performed using custom written scripts in Matlab (MathWorks,
USA). Statistical measurements were performed using GraphPad Prism version 6.0
(GraphPad Software, USA).
For normally distributed numerical data (p ≥ 0.05, Shapiro-Wilk test), parametric
tests were used (i.e. paired or unpaired student’s t-tests). Welch correction was added
to unpaired data as I could not assume the standard deviations were the same.
If data was found not to be normally distributed (p <0.05, Shapiro-Wilk test), non-
parametric tests were used. For unpaired data this included the Mann-Whitney U test
(referred to as Mann-Whitney test) while for paired data the Wilcoxon signed-rank test
(referred to as Wilcoxon test) was used.
Categorical data was summarised in contingency tables and differences between
groups were identified using the Fisher-exact test.
Significance was defined as a p-value <0.05. Data is reported as mean ± standard
error of the mean (SEM) unless otherwise stated.
When comparing the effect of diazepam on various manually measured SLE and LRD
parameters, data was randomised and the treatment groups blinded by an independent
party. Analysis was then performed not knowing which recordings had diazepam added.
Data was unblinded only after the statistical analysis was performed. This was done to
eliminate any bias introduced by manual analysis of the recordings.
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3.1 Benzodiazepine-resistant status epilepticus is
prevalent in a South African paediatric cohort
To give a clinical context to my experimental research, I sought to determine the local
prevalence of benzodiazepine-resistant convulsive status epilepticus (CSE). To achieve
this, a sample was taken from a cohort of patients that had been recruited into an ongoing
clinical trial. The aim of this clinical study is two-fold: (i) to study the epidemiology
of CSE in the local paediatric population and (ii) to assess the response to current,
unvalidated treatment protocols. However, for the purpose of this thesis, I performed a
limited interim analysis to measure the prevalence of benzodiazepine-resistant CSE in a
South African paediatric cohort.
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At the time this analysis was performed, 144 entries had been loaded into the study
(see Figure 3.1, A). 106 (74%) of these had been reviewed while 38 (26%) are still
pending review. Moreover, of those patients who’s folders had been reviewed, 13 (12%)
were excluded from the study. This was done if the patient either did not satisfy the
definition of CSE at admission or if the record of their admission was incomplete (as
described in Section 2.1.1). Of the remaining eligible patients, I only analysed their first
admission into the study.
As shown in Figure 3.1, of the 73 patients included in the interim analysis, 42% did
not respond to first-line benzodiazepine agents that included either diazepam, lorazepam
or midazolam given either intravenously (IV) or per rectally (PR). In the sample of the
cohort used, 52% were female and 48% males. The median age was 24.95 months with
an interquartile range of 38.59 months. Furthermore, there was no significant difference
in age between the benzodiazepine-sensitive vs benzodiazepine-resistant patients (42.20
± 5.64 months vs 33.95 ± 6.58 months, p = 0.16, Mann-Whitney test). However, when
looking at the time between seizure onset and time to delivery of the first-line agent,
this was significantly longer in the benzodiazepine-resistant group (45.93 ± 5.45 minutes
vs 68.29 ± 8.65 minutes, p = 0.018, Mann-Whitney test). The median time of seizure
duration was 45 minutes with an interquartile range of 52.5 minutes. This suggests
that the longer CSE remains untreated the more likely it is to become resistant to
benzodiazepines.
This data confirmed that benzodiazepine-resistant CSE is a relevant clinical entity
which warrants further investigation into possible cellular mechanisms. This provides
the justification for the in vitro research using animal models which follows.
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Figure 3.1: Local paediatric prevalence of benzodiazepine-resistant convulsive status
epilepticus. A, Flow-diagram showing how the data was selected for the interim analysis. B, The
proportion of the selected patients who are resistant to first-line treatment with benzodiazepines.
C, There was no significant difference in ages between patients in the two groups. D, In the
benzodiazepine-resistant group, there was a significantly longer delay from seizure onset to the
time the first-line benzodiazepine agent was given. ns = not significant (p > 0.05), *p < 0.05.
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3.2 Diazepam enhances GABAAR mediated signaling
The aim of these experiments was to confirm that benzodiazepines positively
modulate GABAAR-mediated fast synaptic transmission. To achieve this, I performed
whole-cell patch-clamp recordings on pyramidal cells whilst eliciting and comparing
GABAAR synaptic currents (GSCs) in the presence of the benzodiazepine, diazepam,
and its competitive antagonist, flumazenil. I repeated these experiments using two
different experimental paradigms.
In the first experiment, I used organotypic brain slices prepared from GAD2-cre-
tdTomato mice (as described in Section 2.2.2 and 2.2.4). At day 1 in culture, I injected
AAV1 containing floxed-STOP channelrhodopsin (ChR2) into the slices using a custom
built pressure ejection system, Openspritzer (Forman et al., 2017). After several days
in culture, ChR2 was progressively and selectively expressed in the GAD2 expressing
interneurons. I then performed voltage-clamp recordings on CA1 pyramidal cells after
6-14 days in culture. To elicit GSCs, I used blue light photoactivation (17.1mW, 100ms)
of the ChR2-expressing interneurons to trigger endogenous synaptic release of GABA.
Pyramidal cells were voltage-clamped at -40mV in order to increase the Cl- driving force.
Moreover, I used a high Cl- internal solution (141mM) to artificially load the cell with
Cl-. This was done to accentuate GABAAR-mediated signalling. GSCs evoked under
these condition generated negative currents that represent Cl- efflux. In order to prevent
the generation of action potentials, I added the intracellular voltage-gated Na+ channel
blocker, QX314 (5µM), to the internal solution. In addition, to block the activation of
GABAB receptors, I added CGP55845 (10µM) to the perfusing aCSF solution.
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The recording protocol consisted of 30 x 10 second traces in standard aCSF solution.
Light stimulation was triggered 2 seconds into each 10 second trace. I then added
3µM diazepam to the aCSF. A 5 minute delay was set before repeating the stimulation
protocol. This was done to allow for full perfusion of the submerged chamber with
the diazepam-containing solution. Thereafter, in order to reverse any diazepam effect,
I washed in aCSF containing the benzodiazepine competitive antagonist, flumazenil
(0.4µM) and repeated the same recording protocol. For the analysis, I measured the
mean amplitude and time constant (tau). I then compared these metrics across the
different treatment groups.
For the second experiment, I prepared acute brain slices from the GAD2-cre-
tdTomato mice on the same day of the experiment (see Section 2.2.3). Coronal brain
slices including the entorhinal cortex were prepared and I then performed whole-cell
recordings on layer V pyramidal cells. To elicit GSCs in these slices, I electrically
stimulated the surrounding GAD2-interneurons in the presence of the glutamate-receptor
blocker, kynurenic acid (2µM). The same internal solution, blockers and recording
protocol was used as described above.
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3.2.1 Diazepam enhances the decay time constant, but not the
amplitude of light-induced GABAAR synaptic currents in
organotypic brain slices
In organotypic CA1 pyramidal cells (n = 8), diazepam increased the mean amplitude
of the light-induced GSCs compared to baseline (297.70 ± 38.74pA vs 315.00 ± 42.96pA,
p = 0.08, paired t-test), however this result was not statistically significant (see Figure
3.2). The application of flumazenil decreased the current size compared to the diazepam
group (297.40 ± 38.53pA vs 315.00 ± 42.96pA, p = 0.09, paired t-test) with it showing
no difference compared to the baseline GSCs (297.70 ± 38.74pA vs 297.40 ± 38.53pA,
p = 0.87, paired t-test).
However, diazepam significantly increased the GSC decay time constant (tau)
compared to baseline (43 ± 4 ms vs 57 ± 6 ms, p = 0.004, paired t-test). This was
then reversed by the flumazenil (57 ± 6ms vs 40ms ± 4ms, p = 0.005, paired t-test).
There was no difference between the time-constants of the baseline and flumazenil groups
(43 ± 4ms vs 40 ± 4ms, p = 0.50, paired t-test).
Figure 3.2 (following page): Diazepam enhances the decay time constant but not the
amplitude of light-induced GABAAR currents in organotypic brain slices. A, Whole-cell patch-
clamp recordings (n = 8) from CA1 pyramidal cells in organotypic brain slices. B, During 10s
sweeps, GABAAR synaptic currents (GSCs) were elicited at 2s by photoactivation (17.1mW,
100ms) of ChR2-expressing interneurons. The mean GSC was calculated from 30 traces in each
of the different treatment groups: baseline (B, black), diazepam - 3µM (D, red) and flumazenil -
0.4µM (F, purple). C, Population data of mean GSC amplitudes in each of the treatment groups
showing no significant difference between them. D, Deactivation kinetics of GABAAR could be
fitted by a single exponential function (grey line) to allow for the decay time constant (tau) to
be calculated. E, Population data of taus for each group showing that diazepam significantly
increased the taus, with this effect being reversed by the application of flumazenil. ns = not
significant (p > 0.05), **p ≤ 0.01. DG - dentate gyrus.
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3.2.2 Diazepam enhances both the amplitude and the decay time
constant of GABAAR synaptic currents in acute brain slices
As shown in Figure 3.3, in acute brain slices (n = 8), diazepam significantly increased
the amplitude of the electrically-evoked GSCs (216.50 ± 33.58pA vs 350.80 ± 56.00pA, p
= 0.003, paired t-test). This was then reversed by the application of flumazenil (350.80
± 56.00pA vs 215.40 ± 31.64pA, p = 0.003, paired t-test). There was no difference
in amplitude between baseline and flumazenil groups (216.50 ± 33.58pA vs 215.40 ±
31.64pA, p = 0.94, paired t-test).
In addition, diazepam lengthened the decay time constant compared to baseline (24
± 2ms vs 32 ± 3ms, p = 0.001, paired t-test) and flumazenil (32 ± 3ms vs 24 ± 2ms, p
= 0.003, paired t-test). Again, there was no difference between baseline and flumazenil
groups (24ms ± 2ms vs vs 24 ± 2ms, p = 0.84, paired t-test).
Through these experiments, I was able to confirm that diazepam positively modulates
GABAAR-mediated synaptic currents in both organotypic and acute brain slice
preparations. Furthermore, this effect is reversed by the application of the competitive
antagonist, flumazenil.
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Figure 3.3 (following page): Diazepam enhances the amplitude and decay time constant of
GABAAR currents in acute brain slices. A, Whole-cell patch-clamp recordings (n = 7) from
layer V pyramidal cells in entorhinal cortex in mouse acute brain slices. B During 10s sweeps,
GABAAR currents (GSCs) were elicited by electrical stimulation of afferent fibers (2pA, 3ms)
in the presence of the glutamate receptor blocker, kynurenic acid (2µM). The mean GSC was
calculated from 30 traces in each of the different treatment groups: baseline (B, black), diazepam -
3µM (D, red) and flumazenil - 0.4µMM (F, purple). C, Population data of mean GSC amplitudes
in each of the treatment groups showing a significant increase in GSC size in the presence of
diazepam that was then reversed by flumazenil. D, Deactivation kinetics of GABAAR currents
could be fitted by a single exponential function (grey line) to allow for the time constant (tau) to
be calculated. E, Population data of taus for each group showing diazepam significantly increased
taus with this effect being reversed by the application of flumazenil. ns = not significant (p >
0.05), **p ≤ 0.01. S - subiculum, MEnt - medial entorhinal cortex, LEnt - lateral entorhinal
cortex, DG - dentate gyrus.
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3.3 0 Mg2+ is a reliable in vitro model of status epilepticus
To study the effect of diazepam on prolonged seizure states, I first needed to establish
a working in vitro model of SE. Previous data suggested that the 0 Mg 2+ model reliably
elicits both single seizure-like events (SLEs) followed by recurrent bursting activity
known as the late recurrent discharge (LRD) phase (Zhang et al., 1995; Albus et al.,
2008). The LRD phase is thought to be an in vitro replica of the ongoing unrelenting
epileptiform discharges that occurs during SE.
In these experiments, I performed local field potential recordings in organotypic and
acute brain slices using an interface perfusion chamber (see Section 2.5.1). The recording
protocol would include a 5-10 minute calibration period in standard aCSF, whereafter I
would remove Mg2+ from the aCSF (0 Mg2+). I then noted the differences in SLE and
LRD propensity between the organotypic and acute brain slices. In addition, the time
delay from when 0 Mg2+ was washed to the onset of SLE and LRD was calculated.
3.3.1 The 0 Mg2+ model elicits prolonged seizure states in both
organotypic and acute brain slices
Recordings were made from the CA1 region of organotypic brain slices (n = 52) and
entorhinal cortex in acute brain slices (n = 64) (see Figure 3.4). SLEs were elicited in
79% of the organotypic brain slices (n = 41) and 64% of the acute brain slices (n = 41).
However, of these slices only 54% of the organotypic brain slices (n = 22) and 32% of
the acute brain slices (n = 15) continued into the LRD phase. There was no significant
difference in SLE propensity (p = 0.15, Fisher’s exact test) or LRD propensity (p =
0.18, Fisher’s exact test) between the different tissue preparations.
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Interestingly, organotypic brain slices appear to have SLEs more rapidly compared
to acute brain slices (533.12 ± 30.09s vs 2183s ± 149.70s, p <0.0001, Mann-Whitney
test). Moreover, organotypic brain slices go into the LRD phase sooner than acute brain
slices (1365.23 ± 112.20s vs 5461s ± 403.80s, p <0.0001, Mann-Whitney test).
From this data, I was able to confirm that the 0 Mg2+ model can reliably elicit
prolonged seizure activity in vitro. Furthermore, there appear to be differences in SLE
and LRD onset times between the organotypic and acute brain slice preparations.
Figure 3.4 (following page): The 0 Mg2+ in vitro model of status epilepticus. A, Local
field potential recording from CA1 in an hippocampal organotypic slice on an interface perfusion
chamber. The recording starts with a 10 min calibration in standard aCSF (Std, grey) followed
by washing in 0 Mg2+ (purple). The time from 0 Mg2+ wash in to first seizure-like event
(SLE, orange) and entry into the late recurrent discharge phase (LRD, blue) are depicted. B, A
recording from entorhinal cortex in an acute brain slice. C, The organotypic brain slices (black
outline) tended to have a higher propensity for SLEs and LRD compared to acute brain slices
(grey outline), but this was not statistically significant. D, Organotypic brain slices have SLEs
sooner and more rapidly enter into the LRD phase compared to acute brain slices. ns = not
significant (p > 0.05), ****p ≤ 0.0001.
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3.4 Differential effect of diazepam on the 0 Mg2+ in vitro
model of status epilepticus
Having established a working 0 Mg2+ model of SE, I then sought to study the effect
of diazepam on these prolonged seizure states. In order to extend data from previous
studies (Zhang et al., 1995; Dreier et al., 1998; Albus et al., 2008), the aim of these
experiments was to investigate the effect of diazepam on the evolution of seizure activity
in the 0 Mg2+ model using organotypic brain slices.
To achieve this, I setup three different experimental paradigms (see Figure 3.5). The
first was a control group (n = 13) where after the 5-10 minute calibration period 0 Mg2+
was washed in. The second, the early group (n = 10), included washing in diazepam
(3µM) with the 0 Mg2+. The third, the late group (n = 9), only introduced diazepam
after LRD was established. Various properties of epileptiform activity were measured
including the time to SLE onset, SLE duration, the frequency of SLEs prior to entry
into the LRD phase and the time to the onset of the LRD phase. In addition, a 60
second window of LRD activity was analysed. This window was taken at a standard
point across all three groups, exactly 7 minutes after the onset of LRD. This includes
the 2 minutes of ongoing bursting activity to confirm entry into the LRD phase (Section
2.6.2). Furthermore, a 5 minute delay was then added to accommodate full perfusion
of the interface chamber with a new solution. This was relevant to the late group when
diazepam was only introduced after initiation of the LRD phase. Within these 60 second
windows, I then measured the discharge duration, frequency and inter-discharge interval.
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For the analysis, I only included recordings if they did not have any SLEs during the
5-10 minute calibration period. Furthermore, recording needed to display SLEs followed
by LRD. Traces where only SLEs or LRD existed were not included. Importantly, in
order to eliminate any possibility of bias introduced during the analysis, the experimental
traces were randomised and I was blinded to which treatment group they belonged to
(as explained in Section 2.8).
3.4.1 Early application of diazepam has a significant anticonvulsant
effect while late application augments bursting activity in the
LRD phase
As illustrated in Figures 3.5 and 3.6, when diazepam is introduced early, it
significantly delayed the onset of SLEs compared to the control (522.15 ± 45.93s vs
799.73s ± 89.81s, p =0.003, Mann-Whitney test) and late groups (548.8 ± 34.46s vs
799.73 ± 89.81s, p =0.008, Mann-Whitney test). Moreover, washing diazepam in early
significantly decreased SLE duration compared to control (21.04 ± 1.69s vs 14.57 ±
1.66s, p =0.013, unpaired t-test) and late groups (27.41 ± 2.72s vs 14.57 ± 1.66s, p
=0.001, unpaired t-test). Furthermore, there was a significant decline in SLE frequency
before entry into the LRD in the early group compared to control (10.85 ± 1.66 vs 5.00
± 3.06, p =0.01, unpaired t-test) and late groups (11.33 ± 1.78 vs 5.00 ± 3.06, p =0.005,
unpaired t-test). There was no difference between the control and late groups in SLE
onset (522.15 ± 45.93s vs 548.8 ± 34.46s, p =0.50, Mann-Whitney test), duration (21.04
± 1.69s vs 27.41 ± 2.72s, p =0.07, unpaired t-test) or frequency (10.85 ± 1.66 vs 11.33
± 1.78, p =0.85, unpaired t-test). Taken together this demonstrates that diazepam has
a significant anticonvulsant effect on the 0 Mg2+ model when it is applied early.
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In terms of entry into the LRD phase, in the early group there was a significant
delay vs the control (1429 ± 187.1s vs 2623 ± 513.9s, p =0.03, Mann-Whitney test) and
late groups (1274 ± 169.2s vs 2623 ± 513.9s, p =0.0004, Mann-Whitney test). Within
the defined 60 second analysis windows, there was a significant increase in discharge
duration between both the control versus early (2.4 2± 0.41s vs 4.44 ± 0.68s, p =0.02,
Mann-Whitney test) and late groups (2.42 ± 0.41s vs 4.72 ± 2.62s, p =0.02, Mann-
Whitney test). Furthermore, there was a significant decrease in discharge frequency in
the 60 second window between control versus the early (12.92 ± 1.77 vs 7.10 ± 1.52, p
=0.0005, Mann-Whitney test) and late groups (12.92 ± 1.77 vs 7.44 ± 0.99, p =0.01,
Mann-Whitney test). There was no difference between early and late groups in either
discharge duration (4.44 ± 0.68s vs 4.72 ± 2.62s, p =0.81, unpaired t-test) or frequency
(7.10 ± 1.52 vs 7.44 ± 0.99, p =0.76, unpaired t-test). Although it is not shown in
Figure 3.6, there was no significant difference in the inter-discharge interval between
the control and the early (5.20 ± 0.72 vs 6.00 ± 1.05, p =0.51, Mann-Whitney test) or
late groups (5.20 ± 0.72 vs 6.56 ± 0.88, p =0.25, Mann-Whitney test). These findings
suggest that the presence of diazepam once LRD has been established does not reduce
epileptiform activity. On the contrary, diazepam increases the duration of discharges
without affecting the inter-discharge interval.
From these experiments I have demonstrated that diazepam has a differential effect
on evolution of epileptiform activity using the 0 Mg2+ model depending on whether it
is applied ‘early’ or ‘late’.
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Figure 3.5 (following page): Differential effect of diazepam on the 0 Mg2+ model of status
epilepticus in organotypic brain slices. A, Control experiment where 0 Mg2+ was washed in after
a 5-10 minute calibration period. Time to SLE onset (orange) and entry into the LRD phase
(blue) are marked. B, Early application of diazepam (3µM) introduced when 0 Mg2+ is washed
in. C, Late group where diazepam only washed in after the LRD phase had been established.
Windows t1-3 highlight individual SLEs shown in Figure 3.6, A. Windows t4-6 highlight 60s of
LRD used for analysis as shown in Figure 3.6, E.
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Figure 3.6 (following page): Population data showing the differential effect of diazepam
on the 0 Mg2+ model of status epilepticus in organotypic brain slices. The data in this figure
follows from the experimental paradigms presented in Figure 3.5. A, t1-3 showing individual SLEs
from the control (t1), early (t2) and late groups (t3). B, Population data showing that early
introduction of diazepam delays SLE onset whilst decreasing SLE duration, C, and frequency
before entry into the LRD phase, D. E, t4-6 marking the 60 second windows used to analyse
LRD activity in the control (t4), early (t5) and late groups (t6). F, Population data showing
that diazepam delays onset of LRD in the early group. The presence of diazepam in the early
and late groups increases discharge duration, G, while decreasing discharge frequency, H. ns =
not significant (p > 0.05), * p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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3.5 GABAergic signalling is strongly depolarising during
the late recurrent discharge phase
Previously in this Chapter (see Section 3.2), I showed that diazepam positively
modulates GABAAR-mediated signalling. Having now shown that diazepam has a
differential effect on the evolution of in vitro SE (see Section 3.4), I then focused on
exploring changes in the properties of GABAAR-mediated signalling during these states.
While previous work has confirmed a transient excitatory shift in GABAAR function
during single SLEs (Ilie et al., 2012; Ellender et al., 2014), to date there is no data
confirming whether this may still be relevant in the LRD phase which models SE.
3.5.1 Optogenetic activation of interneurons drives excitatory
signalling in the evolution of prolonged seizure states
Using the same optogenetic paradigm described in Section 3.2, I performed whole
cell recordings on CA1 pyramidal cells in organotypic brain slices (n = 7). Voltage-
clamp was used with cells clamped at -40mV using a standard internal solution (see
Section 2.4.2). The ChR2 expressing GAD2-interneurons were then activated every 7s
with 100ms of blue-light illumination. After 3 minutes of recording in standard aCSF, 0
Mg2+ was washed in and SLEs and LRD allowed to develop. After at least 5 minutes of
LRD, I then reintroduced standard aCSF in an attempt to arrest the LRD phase. Only
traces with both SLEs and LRD were included in the analysis.
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In order to study changes in the light-induced currents, I used a combination of both
automated and manual detection methods to measure the size and direction of these
currents. Figure 3.7 demonstrates the experimental protocol using current-clamp. Figure
3.8 then shows the same protocol in voltage-clamp with population data highlighting
the changes in light-induced currents. The light-induced currents are an unspecified
combination of both GABAAR, GABABR and possibly disynaptic glutamate receptors.
There was a significant positive shift in the direction of light-induced currents during
a single SLE, t2, vs baseline, t1 (448.80 ± 70.34pA vs -752 ± 88.67pA, p =0.0002, paired
t-test). This would recover after the SLE had self-terminated. There was a significant
change in the currents during SLE recovery, t3, versus those seen during the after-
discharge phase of the SLE, t2 (-752.00 ± 88.67pA vs 536.50 ± 134.90pA, p =0.0007,
paired t-test). Furthermore, light-induced currents during the LRD phase, t4, were
significantly more depolarising compared to recovery after the single SLE, t3 (536.50
± 134.90pA vs -894.00 ± 164.80pA, p =0.0018, paired t-test). After reintroduction of
Mg2+-containing aCSF and termination of LRD, the currents again became significantly
hyperpolarising, t6, compared to those observed during the LRD phase, t4 (-894.00 ±
164.80pA vs 242.00 ± 21.21pA, p =0.0005, paired t-test). There was no significant
difference in amplitude between induced currents during SLE, t2, and LRD, t4 (-752.00
± 88.67pA vs -894.00 ± 164.80pA, p =0.18, paired t-test). However, the light-induced
currents appear significantly smaller after recovery from LRD, t6, compared to baseline,
t1 (242.00 ± 21.21pA vs 448.80 ± 70.34pA vs, p =0.04, paired t-test).
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3.5.2 Prolonged seizure activity leads to a significant decrease in light-
induced GABAergic conductances
In comparing the amplitude of the light-induced currents before and after seizure
activity (see Figure 3.9), there was a significant decrease between baseline (t1) and
recovery (t6) (448.80 ± 70.34pA vs 242.00 ± 21.21pA, p =0.04, paired t-test).
Furthermore, step protocols performed before baseline and after recovery (see Figure
3.7) show a significant decrease in conductance in the light-induced currents (17.79 ±
5.93nS vs 12.37 ± 5.18nS, p =0.02, Wilcoxon test). Importantly, there was no change
in access resistance (15.50 ± 1.87mΩ vs 17.12 ± 5.91mΩ, p =0.13, paired t-test) nor in
membrane potential (-58.75 ± 2.22mV vs -59.37 ± 2.36mV, p =0.19, paired t-test). This
confirms that the observed decrease in current amplitude and conductance was not as a
consequence of the whole-cell recording deteriorating over time.
Figure 3.7 (following page): Transient shifts in the effect of GABAergic interneurons during
the evolution of prolonged seizure activity. A, Current-clamp recording from a CA1 pyramidal
cell in an organotypic slice with photoactivation of ChR2-expressing GAD2 interneurons (100ms
every 7s at 17.1mW). After 3 minutes of recording in standard aCSF (Std, grey), 0 Mg2+ aCSF
(purple) was washed in. After at least 5 minutes of late recurrent discharge (LRD) activity,
standard aCSF was washed in. The boxes labelled (t1-6) mark 30 second windows of the trace.
B, Expanded view of the t1-6 windows. t1 is taken from baseline, t2 during the after-discharge
phase of a single seizure-like event (SLE), t3 recovery after single SLE, t4 cut-out of activity
during LRD, t5 during recovery in standard aCSF showing sudden change in size and direction
of light-induced currents and t6, a cut-out of activity when the slice had fully recovered in
standard aCSF.
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Figure 3.8 (following page): Activation of GAD2 interneurons results in depolarising currents
in pyramidal cells during single and prolonged seizures. A, Voltage-clamp recording from a CA1
pyramidal cell in an organotypic slice clamped at -40mV. Photoactivation of ChR2-expressing
GAD2 interneurons (17.1mW, 100ms) occurred every 7 seconds. After 3 minutes of recording in
standard aCSF (Std, grey), 0 Mg2+ aCSF (purple) was washed in. After at least 5 minutes of
late recurrent discharge (LRD) activity, standard aCSF was again washed in. The boxes labelled
(t1-6) mark 30 second windows of the trace. B, Expanded view of the t1-6 windows where t1
is taken from baseline, t2 is taken during the after-discharge phase of a single seizure-like event
(SLE), t3 is taken during recovery after single SLE, t4 is a cut-out of activity during LRD, t5
is taken during recovery in standard aCSF showing sudden change in size and direction of light-
induced currents and t6 is a cut-out of activity when the slice had fully recovered in standard
aCSF. C, Population data showing significant changes in current size and direction across the
different time intervals t1-4 and t6. *p ≤ 0.05), **p ≤ 0.01, ***p ≤ 0.001.
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Figure 3.9 (following page): Changes in baseline GABAergic signalling before and after
prolonged seizure activity. A, Whole-cell voltage-clamp recording from a CA1 pyramidal cell in
an organotypic brain slice clamped at -60mV using an internal solution containing 10mM of Cl-.
A voltage step protocol was followed starting at -100mV and ending at -40mV progressing in
10mV increments. At 1 second after each voltage step, ChR2-expressing GAD2 interneurons were
activated with 100ms of blue light (17.1mW). The grey dotted line marks the holding current
at each step. The red dotted line marks the GABA currents elicited by photoactivation. The
baseline (black) was taken before 0 Mg2+ wash in (before t1 in Figures 3.7 and 3.8). The recovery
(blue) was taken after the network had fully recovered from LRD (after t6 in Figures 3.7 and
3.8). B, A current-voltage (IV) plot showing intersection of baseline and light-induced currents
at different holding voltages. Reversal potential for the light-induced GABA current EGABA is
marked by the black arrow. C, Population data showing no difference in EGABA between baseline
and recovery. D, There was a significant difference in conductance of the light-induced GABA
current in the recovery phase compared to baseline. The was no difference in access resistance,
E, or membrane potential, F, between the step protocols in the baseline and recovery groups.
ns = not significant (p > 0.05), ***p ≤ 0.001.
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3.6 Synchronised activation of GAD2 interneurons
entrains network activity during the LRD phase
through GABAAR signalling
In previous experiments (see Figures 3.7 and 3.8), I show how photoactivation of
GAD2 interneurons drives strongly depolarising currents during the LRD phase. I then
noted that the epileptiform discharges that occur during the LRD could be elicited by
photoactivation of interneurons (see Figure 3.10). During a 5 minute analysis period
taken from the LRD phase, I analysed traces in 7 second frame windows, with light
activation occurring 3.5 seconds into the 7 second window. This 7 second window
was then divided into smaller 200 millisecond time bins whereby the probability of an
epileptiform discharge being initiated could be calculated.
I observed that the probability of eliciting a discharge increased to 0.78 ± 0.06
during the 200 milliseconds immediately following light application. Furthermore, the
probability of the being in a discharge increased for several seconds following light-
activation. This suggests that optogenetic activation of GAD2 interneurons entrains the
hippocampal network during the LRD phase.
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Figure 3.10: Photoactivation of GAD2 interneurons significantly increases discharge probability
in the LRD phase. A, Whole-cell voltage-clamp recording from a CA1 pyramidal cell in an
organotypic slice clamped at -40mV (same trace seen in Figure 3.9). Cut-out is of a 60s window
of LRD showing discharges being initiated by photoactivation. B, Population data from 7 slices.
Left axis (black, histograms with ± SEM) represents the probability of a discharge being initiated
in any given 200 millisecond time bin within a 7 second window from a 5 minute LRD analysis
period. The right axis (blue, line plot with ± SEM) represents the probability of a discharge
being present at the time of photoactivation.
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3.6.1 Synchronised activation of GAD2 interneurons is responsible for
entraining the hippocampal network during the LRD phase
To provide further evidence to support that this entrainment is indeed due to
photoactivation of GAD2 interneurons, I then performed a control experiment to
compare discharge probability before and after photoactivation (see Figure 3.11). To
do this, I switched on the light only after a minimum of 5 minutes of LRD activity had
occurred. The discharge probability at the point the light was switched on significantly
increased (0.06 ± 0.02 vs 0.53 ± 0.09, p =0.002, paired t-test).
Figure 3.11 (following page): Network entrainment follows photoactivation of GAD2
interneurons during the LRD phase. A, Whole-cell voltage-clamp recording from a CA1
pyramidal cell in an organotypic brain slice clamped at -40mV. This trace represents a 10 minute
window from the onset of LRD. t1 and t2 are 60 second windows of activity before and after
photoactivation (17.1mW, 100ms) was initiated. B, Population data (n = 7) from the 5 minute
analysis window showing the probability of a discharge initiation in 200 millisecond time bins
(black, histograms with ± SEM) as well as the probability of a discharge occurring at any point
during the 7 second window (blue, line plot with ± SEM). C, Population data showing the
mean change in discharge and event probability after photoactivation was initiated. D, Graph
highlighting how discharge probability significantly increases when the blue light is switched on.
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3.7 Blocking the GABAAR reverses network entrainment
via optogenetic activation of GAD2 interneurons
Lastly, to test whether excitatory GABAAR signalling was responsible for these light-
induced discharges, I added the GABAAR blocker, picrotoxin (100uM), to the perfusing
aCSF after at least 5 minutes of LRD activity (see Figure 3.12). The picrotoxin did not
arrest the LRD activity. However, I did note that the discharge probability following
the light stimulus decreased significantly (0.64 ± 0.08 vs 0.08 ± 0.03, p =0.03, Wilcoxon
test).
Figure 3.12 (following page): The GABAAR antagonist, picrotoxin, decreased network
entrainment by photoactivation of GAD2 interneurons. A, A whole-cell voltage-clamp recording
from a CA1 pyramidal cell in an organotypic brain slice clamped at -40mV. This trace is a 10
minute window from the onset of LRD with light-stimulus (100ms) every 7 seconds. After at
least 5 minutes of LRD activity, picrotoxin (100µM) was washed in. t1 and t2 are 60a windows
of activity before and after picrotoxin (orange) was washed in. B, Combined graph of population
data (n = 6) from the 5 minute analysis window showing the probability that photoactivation
initiates a discharge (black, histograms with ± SEM) and the probability of a discharge bring
present is shown in blue (line plot with ± SEM). C, Population data showing the mean change
in discharge and event probability after picrotoxin was washed in. D, Graph highlighting how
discharge probability significantly decreased in the time bin following when the blue light was
switched on in 0 Mg2+ versus when picrotoxin had been added (orange). **p ≤ 0.01.
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3.7.1 The frequency of epileptiform discharges during the LRD phase
is affected by synchronised activation of GAD2 interneurons
In the previous experiments (see Figures 3.10, 3.11 and 3.12), I showed how
photoactivation GAD2 interneurons can entrain the hippocampal network. I then noted
that this entrainment could affect the frequency of epileptiform discharges. This is
illustrated in Figure 3.13 (A) where it appears that within a 5 minute analysis period,
whenever photoactivation occurs (‘LED on’), 30% of the discharges follow the frequency
at which the light stimulus is activated (0.14 Hz). In comparison, if the light is off (‘LED
off’) or picrotoxin is present (Px) there is a wider distribution of frequencies at which
the discharges occur.
This was then confirmed by calculating the difference between the frequency at which
the light was activated and the frequency of discharges within the 5 minute analysis
window (see Figures 3.13, B). This difference is smaller in the ‘LED on’ group compared
to the ‘LED off’ group (0.04 ± 0.02 vs 0.12 ± 0.03, p =0.03, Mann-Whitney test) and Px
(0.04 ± 0.02 vs 0.12 ± 0.02, p =0.04, Mann-Whitney test) groups. Taken together, this
suggests that the frequency at which the recurrent epileptiform discharges occur during
the LRD phase can be mediated by optogenetic activation of GABAergic signalling.
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Figure 3.13: Synchronised photoactivation of GAD2 interneurons and blocking of the GABAAR
affects epileptiform discharge frequency during the LRD phase. A, Cumulative percentage
plot showing the distribution of discharge frequencies across the three groups, control with no
photoactivation (LED off, n = 7), photoactivation (LED on, n = 7) and photoactivation with
100µM picrotoxin washed in (Px , n = 6). Grey lines mark x1 and x2 the frequency of the light
stimulus (0.14Hz and 0.28Hz). B, Population data showing the difference between frequency of
photoactivation (x1 grey line in A) and the observed frequency of discharges within a 5 minute
analysis window. In the LED on group, this difference is significantly smaller when compared to
the LED off and Px groups. ns = not significant, *p ≤ 0.05.
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3.8 Studying activity-driven changes in intracellular Cl-
concentration
As GABAARs are largely permeable to Cl
-, I used the gramicidin perforated patch-
clamp technique to measure the EGABA without perturbing the [Cl
-]i (see Section 2.4.3
and 2.4.4). Once a gigaseal has been achieved, gramicidin perforates the cell membrane
with cation-specific pores. While this gives electrical access to the cell, the gramicidin
does not permit the passage of Cl- and thereby maintains the transmembrane Cl-
gradient.
In order to measure EGABA, I activated the GABAAR in one of two ways (see Section
2.4.4). First, GABA (100µM) was puffed on the soma using a pressure ejection system.
Alternatively, ChR2-expressing GAD2 interneurons where stimulated with blue light to
trigger the release of endogenous GABA. A voltage step protocol similar to that seen in
Figure 3.9 was then used to generate IV plots. These were then used to calculate the
EGABA. I then used the Nernst Equation (Equation 1.3) to calculate the [Cl
-]i. The
[Cl-]e I used for solving the Nernst equation was the Cl
- of the standard aCSF solution
(123mM).
3.8.1 Both endogenous and exogenous GABA application can be used
to determine the intracellular concentration of Cl- in organotypic
brain slices
As illustrated in Figure 3.14, by combining the data from the puffed and light-
stimulated GABA (n = 16), I was able to calculate a mean EGABA of -80.80 ± 2.39mV
from which I was able to calculate a mean [Cl-]i of 5.65 ± 0.53mM.
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It is worth noting that the [Cl-] in the internal solution was 141 mM which is much
higher that the calculated [Cl-]i. This indicates that it is likely that the integrity of
the gramicidin perforated patches were well maintained. Furthermore, there was no
difference in conductance of the GABA currents elicited by exogenous (n = 10) vs
endogenous (n = 6) GABA stimulation (11.39 ± 2.28nS vs 7.07 ± 0.69nS, p =0.0.7,
Wilcoxon test). Although not shown in the Figure 3.14, I observed no difference in
membrane potential (-70.65 ± 1.91mV vs -63.74 ± 3.12mV, p =0.21, Wilcoxon test) or
access resistance (65.09 ± 4.67Ω vs 48.77 ± 7.66Ω, p =0.07, Wilcoxon test) between the
two different methods.
Figure 3.14 (following page): Exogenous application of GABA versus optogenetic stimulated
GAD2-interneurons to determine intracellular concentration of Cl- in organotypic brain slices.
A, Gramicidin perforated patch voltage-clamp recordings from CA1 pyramidal cells clamped at
-60mV. The recording protocol included voltage steps in increments of 10mV above and below
-60mV. During each voltage step, either exogenous GABA (100µM) was puffed onto the soma
or ChR2-expressing GAD2 interneurons were stimulated with a light impulse (100ms, 17.1mW).
Grey line marks the holding current for each step while the red line marks the current elicited by
either the exogenous application or endogenous release of GABA. B, Current-voltage (IV) plots
showing GABA current reversal potential (EGABA) calculated at the point where the GABA
current and the holding current intersect. C, Population data of EGABA values obtained using
both methods. D, Estimated [Cl-]i concentrations calculated from EGABA values using the Nernst
equation (Equation 1.3). E, There was no difference in GABA current conductance elicited by
exogenous GABA or ChR2-activated interneurons. ns = not significant.
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3.8.2 Transient, activity-driven changes in intracellular Cl- occur
during single seizure-like events
In this final experiment, I aimed to confirm the transient, activity-driven changes in
[Cl-]i that were observed during single SLEs as previously described by Ellender et al
(2014). As illustrated in Figure 3.15, I performed a perforated patch-clamp recording in a
CA1 pyramidal cell from an organotypic brain slice. The recording protocol alternated
between current and voltage-clamp modes. In voltage-clamp a ramp protocol would
then start starting at -90mV and continuing until -20mV. The ramps were repeated
twice within 1.5 seconds. During the second ramp a GABA conductance was elicited by
exogenous puffs of GABA on the soma in order to determine EGABA at that point.
Seizures were elicited using the 0 Mg2+ model. At the start of a single SLE standard
aCSF containing 2mM Mg2+ was washed in. This was done to terminate the seizure and
allow for accurate measurement of the EGABA that would otherwise be compromised by
ongoing spiking activity during the after-discharge phase. From the ramp protocols, IV
plots could be drawn and the estimated EGABA and [Cl
-]i calculated.
Before the onset of a SLE (t1), I measured the EGABA to be -65.81mV equating
to a [Cl-]i of 9.50mM. However, during the afterdischarge phase of the SLE (t2), both
the EGABA and [Cl
-]i rose to -36.22mV and 30.04mM respectively. Once the cell had
recovered (t3), the EGABA and [Cl
-]i returned to pre-SLE values (-65.24mV and 9.71mM).
This is in keeping with what had been reported by Ellender et al (2014).
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Figure 3.15 (following page): Transient Cl- loading occurs during a single seizure-like event.
A, Using a gramicidin perforated patch-clamp recording, the EGABA was measured at different
stages of a single seizure-like event (SLE). During recording the mode was rapidly switched
between current-clamp (CC - 8 seconds) and voltage-clamp (VC - 1.5 seconds). In voltage-clamp,
two ramp protocols were applied in quick succession of each other. During the second ramp,
GABA (100µM) was puffed onto the cell soma. B, Representative trace from a CA1 pyramidal
cell from a hippocampal organotypic slice. SLEs were elicited using the 0 Mg2+ model. At SLE
onset, 2mM Mg2+ aCSF was washed in to block ongoing spiking activity. EGABA measurements
are marked by blue circles and were sampled prior to SLE onset (t1), during the after-discharge
phase (t2) and at recovery (t3). C, Ramp protocols taken each of the time points, t (1-3). D,
IV plots were drawn and extrapolated to estimate EGABA values. The [Cl
-]i was then calculated
using the Nernst equation (Equation 1.3)
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Discussion
In this final chapter I will discuss the relevance of the major clinical and experimental
findings that have been presented in this thesis. Where appropriate, I will highlight
shortcomings in the methodology and propose avenues for future research.
4.1 Benzodiazepine-resistant status epilepticus is
prevalent within our local paediatric population
The clinical data I have presented in this thesis (see Section 3.1), confirms that
within our local paediatric cohort, 42% of patients who present in CSE do not respond
to first-line treatment with benzodiazepines. I then noticed, that this group of patients
appear to have significantly longer episodes of CSE before receiving treatment.
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These findings are similar to what has been reported in a larger British study by
Chin et al (2008). In their cohort, 187 patients received benzodiazepines as first-line
intervention, with 35% not responding to this treatment. Furthermore, they showed
that patients who require more than 2 doses of benzodiazepines have a significantly
higher risk of going into respiratory depression, a life-threatening complication of
benzodiazepine treatment. This suggests that failure to respond to first-line treatment
with benzodiazepines is associated with increased morbidity in paediatric patients.
A major limitation of the clinical data presented in this thesis is that it is incomplete.
It represents an interim analysis of an ongoing clinical study. A more in-depth analysis is
still to be performed in order to identify potential characteristics that may separate out
the benzodiazepine-resistant group. This will include studying differences in past medical
history, underlying aetiology, semiology, pre-hospital treatment as well as immediate and
long-term outcomes.
Despite this clinical data being limited, it was ultimately successful in achieving
its modest objective. I was able to confirm that benzodiazepine-resistant SE is a
relevant clinical entity within our paediatric population. This has provided a suitable
introduction to my experimental investigation into how changes in GABAergic signalling
may be relevant to benzodiazepine resistance in SE.
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4.2 Diazepam modulates GABAAR synaptic currents
during normal network activity
In Figures 3.2 and 3.3, I showed how diazepam positively modulates GABAAR
synaptic currents (GSCs). I then demonstrated how this can be reversed using the
competitive antagonist, flumazenil. These findings are similar to what has been described
by Deeb et al (2013) who used dissociated cell cultures and elicited GSCs using exogenous
application of the GABAAR agonist, muscimol.
Interestingly, my data seems to suggest that there is a difference in the effect of
diazepam on GSCs between the organotypic and acute brain slices. In the organotypic
brain slices diazepam has a more subtle effect by only affecting the decay constant and
not the amplitude of the GSCs. By contrast, in the acute brain slices diazepam the
effect is more impressive, affecting both the amplitude and decay constant of the GSCs.
This finding may be explained by inherent differences between the two brain slice
preparations. In organotypic brain slices, previous work by Mckinney et al (1997) has
shown that during the preparation of these slices there is significant damage to the
structural integrity of the neural network, mainly in the form of axonal injury. When
these neurons are maintained in culture, axonal sprouting occurs that leads to recurrent
connections being formed between neurons. This causes an overall increase in network
excitability (Dyhrfjeld-Johnsen et al., 2010). The full extent of how this aberrant network
activity affects synaptic transmission, and specifically the distribution and configuration
of GABAARs, is still unknown. Future experiments may aim to provide further insight
into this by studying GABAAR subunits in the organotypic brain slices using various
antibody-labelling and advanced imaging techniques.
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Other important technical differences to consider include the method of activating
GABAAAR signalling as well as the brain area recorded from. Ideally, I would have
preferred using optogenetics in both slice preparations. However, due to technical
limitations this was not possible in acute brain slices. Moreover, it is also unknown
if GABAergic signalling is different between the CA1 (organotypic) and layer 5 of
entorhinal cortex (acute). For this reason, these experiments should be repeated in
equivalent cell populations in both slice preparations.
Lastly, another limitation was that only one benzodiazepine (diazepam) at one dose
(3µM), was studied. This dose was chosen as it had previously been shown to be effective
by Deeb et al (2013). Future experiments could aim to study the effect of different types
and doses of benzodiazepines on GSCs.
4.3 The 0 Mg2+ model provides a reliable in vitro replica
of status epilepticus
Using the Mg2+ model, I demonstrated how SE-like activity could be induced in
both organotypic and acute brain slices (see Figure 3.4). In both tissue preparations,
the introduction of the Mg2+ solution precipitated an increase in slice activity that then
progressed first into single SLEs followed by entry into a phase of recurrent epileptiform
discharges, known as the LRD phase. These findings are consistent with previous in
vitro studies (Dreier and Heinemann, 1991; Zhang et al., 1995; Dreier et al., 1998; Pal
et al., 1999; Deshpande et al., 2008; Albus et al., 2008; Kelley et al., 2016). Therefore,
I have furthered validated that this a reliable model in which to study the evolution of
prolonged seizure activity in vitro.
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Interestingly, there appear to be a significant difference in the SE-like activity
between the different tissue preparations. While there was no significant difference in
SLE or LRD propensity, in the organotypic brain slices SLE and entry into LRD appears
to occur sooner compared to the acute brain slices.
Organotypic brain slices, by themselves, are considered to be a model of post-
traumatic epileptogenesis and have been shown to generate spontaneous seizure activity
while in culture (Dyhrfjeld-Johnsen et al., 2010). The trauma caused by the slicing
procedure in combination with keeping them in culture causes aberrations within the
neural circuitry, as well as widespread cell death (Coltman et al., 1995; Simoni et al.,
2003; Berdichevsky et al., 2012). The consequence is sustained hyperexcitability within
these slices which may explain why there is faster onset of seizure activity in the
organotypic brain slices compared to acute brain slices.
A limitation of my data set is that I only studied a single pro-convulsant model.
There is a difference in patterns of seizure activity between the various in vitro seizure
models, and this may prove to be relevant when studying SE-like activity. For example,
Albus et al (2008) describe distinct differences in the types of seizures generated by
the 0 Mg2+ model compared to using the K+ channel blocker, 4-aminopyridine (4-AP),
to elicit seizure activity. Furthermore, Kelley et al (2016) have demonstrated that the
4-AP model generates repeated SLEs, but never enters into the LRD phase. These
differences between models need to be appreciated as they may significantly alter the
reproducibility of results. Furthermore, these differences may bias the understanding of
underlying ictogenesis as well as the observed sensitivity to anticonvulsants.
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4.4 Diazepam has a differential and time-dependent effect
on in vitro status epilepticus
Having setup the 0 Mg2+ model in organotypic brain slices, I then showed how
diazepam affects the development and progression of prolonged seizure activity (see
Figures 3.5 and 3.6).
When introduced early, diazepam appears to delay the onset of SLEs while also
making them shorter and occur less frequently. However, it did not seem to prevent the
progression into the LRD phase nor was it able to ablate SE-like activity. Interestingly,
I then noticed that the presence of diazepam in the early part of the LRD phase
appears to positively modulate the recurrent epileptiform discharges. Notably, diazepam
increased the duration of discharges without affecting the inter-discharge duration. The
results from these experiments demonstrate how in the 0 Mg+ model, diazepam is first
anticonvulsant and then progresses to enhancing epileptiform activity.
Albus et al (2008) show a comprehensive study of the effect of various anticonvulsants
on organotypic brain slices using the 0 Mg2+ model and therefore provide a useful
reference to compare findings. Interestingly, their use of diazepam (at higher doses
of 5µM and 35µM) also failed to prevent SLE onset and shortened SLEs. However, their
data was not statistically significant nor did they look at the effect of diazepam on other
LRD parameters like discharge duration and frequency.
A limitation of my results is the particular analysis approach used. Currently, the
analysis of LRD activity was limited to discrete 60 second window at a predefined
time point early in the LRD period (7 minute after onset). A more accurate method
of assessing the effect of diazepam on the LRD activity would be to employ a fully
automated approach whereby the individual discharges are detected and analysed across
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a much longer time window. In addition, the effect of diazepam on the amplitude
and power (using a fast fourier transform) should be performed (Glykys and Staley,
2015). Moreover, future experiments could analyse the effect of diazepam on LRD
activity at different time intervals to identify if and when the activity becomes truly
pharmacoresistant and can no longer be positively modulated by benzodiazepines.
Another limitation is that these experiments have only been conducted in organotypic
brain slices. Therefore, to increase the validity of these results the experiments should
be repeated in acute brain slices. Given the impressive effect of diazepam on baseline
GABAAR signalling (as shown in Figure 3.3), it will be interesting to see how diazepam
may affect seizure activity in this preparation.
Despite these limitations, taken together with my data showing how diazepam
positively modulates the GABAAR (see Section 4.2), these findings suggest that
enhancing this receptor’s function during the LRD phase positively modulates the
epileptiform discharges. This implies that the GABAAR-signalling may participate in
SE-like activity.
4.5 GABAergic signalling drives epileptiform discharges
during in vitro status epilepticus
4.5.1 GABAergic signalling is excitatory in both single seizures and
SE-like activity
In the development of prolonged seizure states, I have shown how GABAergic
signalling shifts between being inhibitory and excitatory (see Figures 3.7 and 3.8). This
extends previous in vitro work by showing that excitatory GABAergic signalling is also
present during the LRD phase (Ilie et al., 2012; Ellender et al., 2014).
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My findings appear to contrast what has been proposed by Ledri et al (2014) as
they had previously shown that the activation of GAD2 interneurons is able to suppress
SLEs. However, there are important differences in methodology that may explain this.
Importantly, there is a significant difference in the stimulation protocol they used as they
found the most significant suppressant effect to occur when the light was activated for
prolonged periods of at least 5 seconds. When they only stimulated for 1 millisecond, this
suppressant effect was lost, which is consistent with what I found when I only stimulated
for 100 milliseconds. Taken together, a possible explanation is that prolonged activation
of the interneurons, which are believed to be excitatory during the seizure, may push
them into a period of depolarising block whereby they are no longer able to participate
in the propagation epileptiform activity.
In this work I activated the entire interneuronal population by using ChR2 expression
driven by the GAD2 promoter. However, it may be interesting to determine how
the different subpopulations of interneurons might contribute to SE-like activity. For
example, a recent study by Khoshkhoo et al (2017) has shown that the various classes
of interneurons contribute differently to the initiation and propagation of seizures.
Specifically, using an in vivo model of induced seizures, they show that the parvalbumin
(PV) and somatostatin (SS) interneurons appear to contribute towards maintaining
seizure activity. This is consistent with my own data and with what is proposed by
Ellender et al (2014), who have shown that synchronised activation of PV interneurons
can trigger afterdischarges during individual SLEs. Interestingly, Khoshkhoo et al (2017)
also show that vasoactive intestinal-peptide (VIP) interneurons are involved in curtailing
seizure activity. As these interneurons primarily target the other two interneuronal
subpopulations, they could be viewed as silencing the excitatory activity of PV and SS
interneurons.
Page 98 of 121
CHAPTER 4. DISCUSSION
4.5.2 GABAergic signalling is reduced after prolonged seizure activity
After showing that excitatory GABAergic signalling plays an active role in SE-like
activity, I then showed that there is a significant reduction in the conductance of the light-
activated GABAergic signalling before and after these prolonged seizures (see Figure 3.9).
This finding is consistent with previous data that shows how SE-like activity causes an
internalisation of the GABAAR leading to a decrease in its inhibitory function (Goodkin
et al., 2005; Naylor et al., 2005).
Taken together with the data I have shown in Figures 3.5 and 3.6, this suggests that
the integrity of GABAergic signalling changes as the LRD phase is allowed to progress.
Early in this SE-like activity, GABAARs may remain intact which would explain how
diazepam is able to modulate the duration of epileptiform discharges. However, over time
the prolonged seizure activity drives endocytosis and recycling of GABAARs (Goodkin
et al., 2005), and may reduce their ability to contribute towards seizure activity. It
is therefore assumed that at a certain point the epileptiform discharges will no longer
be sensitive to diazepam. In order to confirm this, further research is needed into how
diazepam affects LRD activity at different time points (as proposed in Section 4.4).
4.5.3 Photoactivation of GABAergic signalling entrains SE-like
activity through the GABAAR
After demonstrating that GABAergic signalling is excitatory during the LRD phase, I
then showed that by controlling GABAergic signalling I am able to alter the probability
of when the recurrent epileptiform discharges occur (Figure 3.10). Furthermore, if a
discharge was not elicited by the activation of the GAD2 interneurons, I found that the
network was more likely to already be within a discharge and therefore refractory to
subsequent activation.
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I then confirmed this observation by showing a significant difference between before
and after photoactivation was initiated (Figure 3.11). Thereafter, I showed how this
entrainment of the LRD activity is mediated by the GABAAR as washing in picrotoxin
was able to disrupt this effect (see Figure 3.12). Interestingly, the GABAAR antagonist
was not able to ablate epileptiform discharges, which suggests that they can be generated
by alternate mechanisms, most likely glutamatergic signalling.
In Figure 3.13, I then showed that by modifying GABAergic signalling, I was able to
alter the frequency of epileptiform discharges during the LRD phase. With synchronised
activation of the GABAergic interneurons I was able to entrain the frequency of the
discharges around the frequency of the light stimulus. By contrast, when the light is off
or the GABAAR is blocked, there is a wider distribution of discharge frequencies.
Taken together, these results suggest that GABAergic interneurons and specifically
GABAAR signalling can precipitate epileptiform discharges during SE-like activity.
However, GABAAR signalling is not solely responsible for generating epileptiform
discharges.
Interestingly, previous work confirms that GABAergic signalling is involved in the
LRD phase, however in an opposing way. Dreier et al (1991) have shown that washing
in picrotoxin accelerates the frequency of discharges during the LRD phase. When the
picrotoxin was then accompanied with the GABABR agonist, baclofen, they noticed
a marked decrease in discharge frequency. By contrast, Albus et al (2008) report
that washing in muscimol during the LRD phase reduces the seizure activity which
seems to suggest that GABAAR-mediated signalling is inhibitory. These experiments
used somewhat crude pharmacological manipulation of the GABAergic system during
SE. Nonetheless, this lack of consensus justifies further research into investigating
how GABAAR-mediated signalling participates in generating and maintaining the
epileptiform discharges during the LRD phase.
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4.6 Seizure-induced changes in Cl-
4.6.1 Using optogenetics to elicit GABAergic inhibitory signalling
While performing perforated patch-clamp recordings, I was able to demonstrate that
using optogenetic activation of GABAergic interneurons is an effective way of eliciting
GSCs in order to measure [Cl-]i (see Figure 3.14). This complements previous work by
Raimondo et al (2012) and further shows how optogenetics can be used to study synaptic
inhibition as well as to study [Cl-]i dynamics.
4.6.2 Transient, activity-driven changes in intracellular Cl- during
single-seizures
In my final experiment (see Figure 3.15), I successfully replicated the results of
Ellender et al (2014). Indeed, I showed that GABAergic signalling does become
excitatory during the after-discharge phase of single SLEs and this is related to an
increase in [Cl-]i. Furthermore, these seizure-induced Cl
- dynamics have also been
imaged using advanced Cl- genetic reporters (Raimondo, Irkle, Wefelmeyer, Newey and
Akerman, 2012; Sato et al., 2017).
This suggests that maintaining Cl- homeostasis is important in limiting seizure
activity. Alfonsa et al (2015) have demonstrated that by inducing Cl- loads using the
light-activated Cl- pump, halorhodopsin, they were able to increase network excitability.
Furthermore, Alfonsa et al (2016) then developed a novel optogenetic Cl- extruder, Cl-
out, that is able to remove Cl- from the intracellular space and in doing so, delay the
propagation of ictal activity.
While the role of these Cl- dynamics have been shown to occur during single seizures,
their relevance during SE-like activity is still to be confirmed.
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4.7 General discussion
In this final section, I will broadly conceptualise how changes in GABAAR function
and structure are responsible for benzodiazepine resistance. I do this by situating the
findings of my thesis within the context of existing literature. I have further summarised
these thoughts in Figure 4.1.
The main finding of my thesis is that excitatory GABAAR-mediated signalling
plays an active part in positively modulating the recurrent epileptiform discharges that
characterise an in vitro replica of SE-like activity. Having confirmed that during single
SLEs, this excitatory GABAergic signalling is linked to a transient increase in [Cl-]i,
I postulate that this short-term ionic plasticity may also be present during prolonged
seizure activity (see Figure 4.1, A). If this is proved to be true, benzodiazepines would
be an ineffective anticonvulsant to treat SE and by enhancing excitatory GABAergic
signalling, may further propel this unrelenting seizure activity.
In order to confirm this link, further research is needed to study Cl- dynamics during
the LRD using either perforated patch-clamp recordings or Cl- imaging techniques.
Another way of confirming this would be to try and reduce [Cl-]i during the LRD phase
using the optogenetic Cl- extruder, Cl-out (Alfonsa et al., 2016). It would be interesting
to see if this would be able to reverse the excitatory shift in GABAergic signalling, as
well as rescue the anticonvulsant effect of benzodiazepines.
Impaired KCC2 function has also been implicated in prolonged seizure activity (see
Figure 4.1, B). Kelley et al (2016) showed that by blocking KCC2 with VU0463271
or knocking it out (using the S940A point-mutant mouse) they were able to accelerate
entry into the LRD phase. It is postulated that the increased [Cl-]i that results from
poor KCC2-mediated Cl- extrusion would drive excitatory GABAergic signalling and
render benzodiazepines ineffective.
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Finally, SE-driven GABAAR trafficking and remodeling needs to be considered (see
Figure 4.1, C). As already discussed (see Section 1.5.3), during SE the GABAAR
undergoes a endocytosis-mediated internalisation. Once internalised, there can be a
reconfiguration of GABAAR subunits which typically involves a replacement of the
α1 and γ2 subunits (needed to form the benzodiazepine binding-site) with α5 and δ
subunits (Friedman et al., 1994; Rice et al., 1996). This reconfigured GABAAR no
longer possesses a benzodiazepine binding-site, and instead is preferentially re-expressed
in the extrasynaptic space. This is likely to represent a more long-term effect (hours to
days) which could also explain benzodiazepine resistance to SE.
In summary, changes in Cl- dynamics and GABAAR expression may provide
an explanation for how the seizure activity becomes resistant to benzodiazepines.
Understanding how these mechanisms relate to each other is a fertile ground for future
study.
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Figure 4.1: Disruptions to GABAAR structure and function may be responsible for
benzodiazepine-resistant status epilepticus. A, Activity-driven intracellular accumulation of Cl-
and extracellular K+ (short-term ionic plasticity). B, Long-term or short-term KCC2 dysfunction
allow for [Cl-]i to rise, leading to an excitatory shift in GABAAR function. C, During SE, the
GABAAR undergoes an endocytosis-mediated internalisation. Once in the intracellular space
the subunits are reconfigured with subunits insensitive to benzodiazepines. The refurbished
GABAAR is preferentially redistributed outside the synaptic cleft.
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4.8 Concluding remarks
In the course of this thesis I have demonstrated that benzodiazepine-resistant SE
is prevalent within our South African paediatric population. I have showed how
benzodiazepines have a differential and time dependent effect on an in vitro model of SE.
My data also demonstrates that excitatory GABAergic signalling plays an active role in
driving epileptiform activity during SE and is likely to represent part of the explanation
for benzodiazepine resistance in SE. Relating my findings to dynamic changes to the
transmembrane Cl- gradient during SE is a pertinent topic for future research.
Taken together the work presented in this thesis may inform the design and choice
of optimum pharmacological strategies for treating SE.
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Appendix
A.1 Protocols for treating paediatric status epilepticus
Included here are the management protocols used by Medical Emergency Unit at
Red Cross War Memorial Children’s Hospital for the treatment of paediatric status
epilepticus (SE). Patients recruited into the above-mentioned clinical study are randomly
allocated to one of the two protocols.
Both protocols use repeated doses of benzodiazepines as first-line management.
Thereafter, in one protocol a patient will then receive repeated doses of phenobarbitone.
This is the preferred clinical practice, however, the use of phenobarbitone for paediatric
SE is not recognised by the Medicines Control Council (MCC) of South Africa. By
contrast, if allocated to the other protocol, after not responding to the benzodiazepines
the patient will receive phenytoin followed by a midazolam infusion. This is the current
recognised practice for managing paediatric SE in South Africa.
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